A clinical study on Samuthra Pazha Nei in the treatment of Neer Peenisam (Maxillary Sinusitis) by Mullaikarasi, U
A CLINICAL STUDY ON SAMUTHRA PAZHA NEI IN THE TREATMENT OF NEER 
PEENISAM (MAXILLARY SINUSITIS) 
The dissertation submitted by 
Dr.U. MULLAIKARASI. 
P.G. Scholar 
Under the Supervision of 
PROF. DR. K. MANICKAVASAKAM M.D (S), 
Head of the Department of Maruthuvam & Former Director 
National Institute of Siddha 
Chennai-47 
 
  
 
 
  
For the partial fulfillment of 
Requirements to the Degree of 
DOCTOR OF MEDICINE (SIDDHA) 
(AFFILIATED TO THE TAMILNADU DR. M.G.R MEDICAL                       
UNIVERSITY) 
BRANCH I – DEPARTMENT OF MARUTHUVAM 
NATIONAL INSTITUTE OF SIDDHA 
TAMBARAM SANATORIUM, CHENNAI– 600 047 
OCTOBER -2017 
 
 DECLARATION BY THE CANDIDATE 
I hereby declare that this dissertation entitled “A CLINICAL STUDY ON SAMUTHRA 
PAZHA NEI IN THE TREATMENT OF NEER PEENISAM (MAXILLARY SINUSITIS)” 
under the Guidance of Dr. H. VETHA MERLIN KUMARI, M.D(s), Lecturer in Department 
of Maruthuvam, National Institute of Siddha, Chennai -47, and the dissertation has not formed 
the basis for the award of any Degree, Diploma, Fellowship or other similar title. 
  
 
 Date:                                                                                Signature of candidate 
Place:Chennai-47                                                                 (Dr.U.MULLAIKARASI)  
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATE 
 Certified that I have gone through the dissertation submitted by Dr. U. Mullaikarasi, 
(Reg.No: 321411204)  a student of Final year MD(S), Branch-I, Department of Maruthuvam, 
National Institute of Siddha, Tambaram Sanatorium, Chennai- 47, and the dissertation work has 
been carried out by the individual only. This dissertation does not represent or reproduce the 
dissertation submitted and approved earlier. 
Place: Chennai-47 
Date: 
 
    
Name and Signature of the Guide             Name and Signature of the HOD 
Dr.H.Vetha Merlin Kumari, MD(S)   Prof.Dr. K. Manickavasakam, M.D(S), 
Department of Maruthuvm    Department of Maruthuvm, 
National Institute of Siddha,       National Institute of Siddha,  
Chennai- 47.                                       Chennai- 47. 
 
 
                                                                                       Forwarded by the Head of the Institution 
                                                                                       National Institute of Siddha, 
                                                                                       Tambaram Sanatorium, 
                                                                                       Chennai- 47. 
 
 
 
 
 
ACKNOWLEDGEMENT 
This dissertation is one of the milestones in the journey of my professional carrier as it is the key 
program in acquiring my MD SIDDHA degree. Thus I came across thistask which kept on 
completed with the support and encouragement of numerous people. So I take great pleasure in 
thanking all the people who made this dissertation study a valuable and successful one, which I 
owe to treasure it. 
I feel enormous wonder and colossal gratitude in my heart of hearts to GOD and SIDDHARS 
Almighty for making this dissertation have its present form.  
I take this opportunity to express my gratitude and acknowledge to the Vice Chancellor             
Dr. S. Geethalakshmi M.D, Ph.D; The Tamil nadu Dr. M.G.R. Medical University, Chennai. 
I express my gratitude to our Director, Prof. Dr. V. Banumathi, M.D(s), National Institute of 
Siddha, Chennai, for giving this opportunity. 
I express my gratitude to our Former Director, & Former head of the department of Maruthuvam, 
Prof. Dr. S. MOHAN, M.D(s), National Institute of Siddha, Chennai, for giving this 
opportunity. 
I express my deep sense of gratitude to Prof. Dr. K. Manickavasakam, M.D(s), Head of the 
Department of Maruthuvam, and Former director, National Institute of Siddha, Chennai, for his 
memorable support and valuable guidance. 
I express my sincere thanks to Dr. N. J. Muthukumar, M.D(s), Hospital superintendent (i/c), 
HOD (i/c), Department of Sirappumaruthuvam, National Institute of Siddha, Chennai.  
I express my sincere thanks to Dr.H. Vetha Merlin Kumari M.D(s), Lecturer, Department of 
Maruthuvam, for her valuable guidance.  
I express my sincere thanks to Dr. N. Periyasamypandian, M.D(s), Associate professor, 
Department of Maruthuvam, National Institute of Siddha, Chennai. 
I express my sincere thanks to Dr. T. Lakshmi Kantham, M.D(s), Lecturer, Department of 
Maruthuvam, National Institute of Siddha, Chennai, for her encouragement. 
I express my sincere thanks to Dr. H. Nalini Sofia, M.D (s), Lecturer, Department of 
Maruthuvam, National Institute of Siddha, Chennai, for her motivation. 
I express my sincere thanks to Dr. D. Aravind, M.D(s), M.Sc [Medicinal Plants], Assistant 
Professor, Medicinal Botany, National Institute of Siddha, Chennai, for his great support in raw 
drug identification and authentication. 
I express my sincere thanks to Dr.A. Mariappan, M.D(s), Lecturer, Department of Gunapadam, 
National Institute of siddha, Chennai, for his guidance in trial drug preparation. 
I express my sincere thanks to Dr. V. Muthuvel, Ph.d; Asst Professor, Biochemistry Laboratory 
(i/c), National Institute of Siddha, Chennai, for his support in Chemical analysis of trial drug. 
I express my sincere thanks to Mr. M. Subramaniyan, M.Sc (statistics), Senior Research 
officer, National Institute of Siddha, Chennai for his guidance in statistical analysis. 
I express my sincere thanks to Dr. D. Sivaraman, M. Pharm, Ph.d, Noble research solutions, 
SathyaBama University, Chennai for his guidance in Pharmacological activity of trial drug. 
I wish to thank the technicians of the Clinical pathology Laboratory, Bio-Chemistry Laboratory, 
and Librarian, National Institute of Siddha, Chennai.  
Last but not least, I would like to pay high regards to all my family members, my father             
Mr.D.Udayakumar,Msw, my mother Mrs.U.Kasthuri and my husband                                     
Dr. E. Lakshmanan, AMO(Siddha) for their sincere encouragement and inspiration throughout 
my research work and lifting me uphill this place of life.  
I extent my hearty thanks to the patients who were participated in this trial, as a human subject. 
 
 
 
 
 
 
    INDEX 
S. NO TITLE PAGE NUMBER 
1. INTRODUCTION 1 
2. AIM AND OBJECTIVES 5 
3. REVIEW OF LITERATURE  
 SIDDHA ASPECTS 8 
 MODERN ASPECTS 22 
4. MATERIALS AND METHODS 41 
 DRUG REVIEW 55 
5. RESULTS AND OBSERVATION 73 
6. DISCUSSION 135 
7. SUMMARY 140 
8. CONCLUSION 143 
9. ANNEXURES 145 
10. BIBLIOGRAPHY 181 
  
   
 
1 
 
 
 
 
 
 
 
 
 
 
 
                             INTRODUCTION  
  
2 
 
INTRODUCTION 
 
 Sinusitis affects a tremendous proportion of the population, accounts for million 
of visits to primary care physicians each year and in the fifth leading diagnosis for 
which antibiotics are prescribed accounting for 0.4% ambulatory diagnosis. According 
to the National Ambulatory Medical Care Survey (NAMCS) approximately 14%adults 
report having an episode of sinusitis each year. 
 Siddha system of medicine has become popular  All over the world which 
ensures prevention and promotion of health/well being through principles of “food is 
medicine and medicine is food” life style modifications, medication etc., and its 
uniqueness in treating diseases. 
Siddha system is said to have originate from the sage agasthiyar tradition 
attributes the beginning of the Indian system of medicine to the inspiration given by 
god to agasthiyar who was specially deputed to cure mankind of the numerous ills and 
diseases. 
 As per agasthiyar Rathina churukam, siddhars classified the diseases into 4448 
types on the basis of three humours and signs&symptoms.Among them the diseases of 
nasal origin are 86 one such disease is peenisam and NEER PEENISAM is one among 
9 types of peenisam. 
 
Á¢¸¢Ûõ Ì¨ÈÂ¢Ûõ §¿¡ö¦ºöÔõ á§Ä¡÷ 
ÅÇ¢Ó¾Ä¡ ±ñ½¢Â ãýÚ.  - -ÌÈû 941 
 
Excess or deficit of any action which produces more or less of the three 
humours beginning with vali(wind) is recokoned by the authors of medical science to 
cause. 
The treatment of siddha medicine is aimed to keeping the three humors in 
equilibrium and maintenance of seven elements. So proper diet medicine and a 
disciplined life and advised for a healthy living and to restore equilibrium of humors in 
diseased condition. 
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 The signs and symptoms of neer peenisam mentioned in yugi vaidhya 
chinthamani such as headache, lacrimation, nasal block, nasal itching, ear discharge, 
running nose, cough with expectoration, absence of taste may be correalated with  
Maxillary sinusitis in modern medicine. 
 In siddha literature “SAMUTHRA PAZHA NEI” (Ref: Aathi siddha 
maruthuvam endra Aathmarathachamirtham ennum vaithya saara sangiragam-first 
edition -2011.,pg no 51 )is specified for peenisam which is the approved text book of 
drug and cosmetic act -1940. The ingredients are Barringtonia cutangula,Linn.,Zingiber 
officinale,Rosc.,Allium sativum,Linn.,Morringaoleifera,Lam.,Plumbago indica,Linn., 
Carum copticum,Benth&hook., Piper nigrum,Linn., Piper longum., Ferula 
asafetida,Linn., Nigella sativa,Linn.,Cissus quadrangularis,Linn., Navacharam & 
Inthuppu in the herbo mineral formulation are found to be possess anti inflammatory, 
anti oxidant, analgesic and anti pyretic actions ,More over the treatment is cost effective 
and the sastric formulation has not undergone any clinical trial so far. 
 Hence I have selected SAMUTHRA PAZHA NEI in the treatment of NEER 
PEENISAM (Maxillary sinusitis). 
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AIM AND OBJECTIVES 
AIM  
 The aim of the study is to evaluate the therapeutic efficacy of a new 
herbomineral drug samuthra pazha nei in the treatment of neer peenisam. 
OBJECTIVES 
Primary objective 
 To evaluate the therapeutic efficacy of the siddha drug samuthra pazha nei in 
reducing the inflammation in neer peenisam (Maxillary sinusitis). 
Secondary objective 
1. To collect and review the ideas mentioned in the ancient literature about the 
disease. 
2. To study other co factors related to the disease such as age, 
sex,occupation,family history, dietary habits, socio economic status,habitate 
etc on the disease 
3. To study the disease neer peenisam on the basis of Siddha principles like 
 Uyir thathukal 
 Udal thathukal 
 Envagaithervu 
4. To evaluate the biochemical analysis of the trial medicine. 
5.To evaluate the physicochemical analysis of the trial medicine. 
6. To evaluate the In-vitro Anti inflammatory activity by protein (Albumin) 
denaturation assay of the trial medicine 
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SIDDHA ASPECTS 
Siddha literature specifies the diseases types based on three dhoshas into 4448 
types. Among them 1008 types of diseases are classified under head and neck region. 
Out of which the disease of nasal origin are 86 in number. Peenisam disease is 
classified into 9 types. Neer peenisam is one among them. 
Synonyms 
 Neer kovai 
 Mookkadaipu 
 Mookuneer paichal 
Definition : 
Characterization of Peenisam are Redness of both nostrils, Redness of both 
eyes, Burning sensation of both eyes, Increased lacrimation, Headache, Continous 
sneezing, Rhinorrhoea, Bleeding from the nostril. 
 
¸ñ¼ ¦ÁØ¸§Å ¾¡¨¼ 
¸¡¸§¾¡ «Å¨¾ô §À¡Äò 
Ðñ¼×ó ¾¢É×õ ÀüÈ¢ò 
ÐõÁ¢§Â ¾ñ½£÷ Å£úóÐ 
Áñ¨¼Ôí ¸ÉòÐ ¦¿¡óÐ 
Å¡¾Óõ À¨¸ìÌÁ¡¸¢ø 
Óñ¼¸ Á¾¢ìÌ Á¡§¾ 
ãìÌ¿£÷ô À¡öîº Ä¡§Á. - Agathiyar gunavaagadam 
 
AS PER AGATHIYAR GUNAVAAGADAM 
 
¦¾Ã¢óÐ ¦¸¡ûÅ¡ö ¿£÷§¸¡¨Å §Ã¡¸ó ¾ý¨É 
¾¢ÈÁ¡¸î ¦º¡øÖ¸¢ý§Èý ¿ýÈ¡öì §¸Ù 
«È¢óÐ ¦¸¡ûÅ¡ö §¾¸ò¾¢ý ºùÅ¢§ÄÛõ 
¬ì¨¸Â¢ý §¾¡ÄÊÂ¢Ä¢ÕìÌõ ºùÅ¢§ÄÛõ 
ÀÃóÐ ¿£÷ þÃò¾É£÷ §º÷Å¾¡§Ä 
ÀÃ¢ÅÐ ¿£÷§¸¡¨Å ¦ÂýÚ §ÀÃ¡öò 
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ÐÃóÐ§Á ¦ÅÇ¢Â¡¸ò §¾¡üÈÄ¡§Ä 
¦¾¡øÖÄ¸¢ø «§¿¸Å¢¾ô §ÀÕÁ¡î§º 
¬îºôÀ¡ º¢Ãº¢ø¾¡ý ¿£§Ã ¸ñ¼¡ø 
«ப௃À§É «¾üÌ ºÄப௄Š¾¸ ¦ப௄ýÀ¡÷ 
§ÀîºôÀ¡ Á¡÷À¢ø ¿£§ÃüÈí ¸ñ¼¡ø 
Ò¸Æ¡É ¯§Ã¡ºÄ §Ã¡¸¦ÁýÀ÷.   - Agathiyar gunavaagadam 
 
 
AETIOLOGY : 
AS PER AGATHIYAR KANMAKAANDA KOWMATHI NOOL-300 
 
À¸Õ§Åý Áñ¨¼Â¢§Ä ¸ÃôÀ¡ý ¸ðÎõ 
À¸ÃÃ¢Â À£É¢ºí¸ Ç¢Ã½ò§¾¡Î  
¿¢¸Ã¢øÄ¡ ¦Å¡Õ¾¨Ä§¿¡ö Áñ¨¼ìÌòÐõ 
¿¢ºÁ¡¸ Åó¾¸ýÁõ ¿¢ºÁ¡öì §¸Ù 
¾¸Ã§Å ¸¡ÂÊò¾ Ä¢¨ÄÀÈ¢ò¾ø 
¾Ç¢÷¦¸¡ØóÐ ¾¨ÆÓÈ¢ò¾ø Àð¨¼¦Åð¼ø 
¿¢¸Ã¢øÄ¡ô âôÀÈ¢ò¾ø §Å÷¦¸¡Ê¸û ¦Åð¼ø 
¿¢¨É×¦¸ðÎî º£Å¦ºóÐ ¾¨ÉÂÊò¾Ä¡§Ä. 
  
 According to agasthiyar kanmakandam 300, peenisam is considered to be a 
karma disease. The activities like pluking leaves, fruits, young shoots, flowers, cutting 
barks, roots, twigs, and hurting animals will cause peenisam. 
 
SIDDHA MARUTHUVAM, ARUVAI MARUTHUVAM, NOI NADAL NOI 
MUDAL NADAL PART (2) 
 
In the above literatures, the aetiology of peenisam is follows, 
 
 Drinking cold water. 
 Exposure to cold. 
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 Exposure to dust. 
 Travel against wind. 
 Smelling of Dust particles which induced sneezing. 
 Drinking cold water while increased body heat. 
 Associated with Mega diseases. 
 Control Vomitting and tears. 
 Shouted voice. 
 Inceased or decreased sleep. 
 
PATHINEN SIDDHAR NAADI SAASTHIRAM & KURUNAADI 
 
À£É¢ºó¾¡ý ÅÃÄ¡Ú ¦º¡øÄì §¸ñÁ¢ý 
§º¾Ó¼ý ¸É¦ÄØõÒ Å¡ö× §º÷òÐ 
°ÚÕ¾¢ Áñ¨¼Â¢§Ä ¦¾¡Îì¸ôÀðÎ 
¯Ú¾¢Ô¼ý Å¡Ô¸í§¸ ÔÚòÐÀ¢ýÛõ 
®ÉÓ¼ý §¿¡Îõ ¿£÷º£ Æ¢Ãò¾õ 
À¢ÊòÐ ¸Õí¸¡Ð ãì¸¢ §É¡Î 
§¾ÉÕÅ¢ Åó¾Û §À¡ø ¦ºí¸ñ º£ÕÂ÷ 
§º÷óÐ Å£Øõ À£É¢ºò¾¢ý ¦ºö¨¸Â¡§Á. 
 
The heat and vayu continue together and affect the head, thereby causing 
peenisam 
 
JEEVARATCHAMIRTHAM (NASIGA ROGA PETHAM) 
 
The literature describes the below etiological features: 
 Exposure to cold air 
 Nasal blockage by dust 
 Loud speech 
 Excess sleep or sleeplessness. 
 Taking bath in cold water daily 
 Controlling the urges and tears 
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 Sleeping in uneven bed 
 Excessive sexual indulgence. 
 
T.V SAMBASIVAM PILLAI MARUTHUVA AGARATHI: 
 
 Mucous discharge through the nostrils is due to an inflammation in the head or 
cold affecting in the nose. 
 Excessive indulgence in sexual intercourse 
 Body heat is transmitted to head 
 Entry of minute particle of dust or smoke into the nostrils 
 Excessive application of heat or cold 
 Voluntary retension of stools and urine 
 Diseases of the nose 
 
CLINICAL FEATURES: 
Asper yugimuni vaithya kaaviyam 
Neer peenisam Gunam:  
ºò§¾ Â¢Õப௄ø Ðõப௄øÅÕõ ƒÄப௄¡ö ãì¸¢ø ¿£÷À¡Ôõ 
Óò§¾À¢¼Ã¢ ÓÊÂ¢¸ðÊ ¦Á¡Õì¸ÄñÊ À¢ÃñÊÂ¢ÕìÌõ 
ÁüÈÅ¢Â¡¾¢ì ¸¢¼í¦¸¡ÎìÌõ Á¡¸¢ø §¸¡¨ÆÁÃ¢òÐ Å¢Øõ 
¿¢ò¾õ §¿¡ö¸û ¿¢¨Èó¾¢ÕìÌõ ¿£÷À£É¢ºÓ¦ÁÉÄ¡§Á.  
 
¾¨ÄÔõ ÅÄ¢ò¾¢ð¦¼¡Õ ¿¡º¢ ºÇ¢§Â Å¢ØóÐ¦Å¡Î×ñ¼¡ö 
Å¨ÄÔõ «ó¿¡§ÇØ ¦ºýÈ¡ø ÅÃñÎþÕ¸¢ò ¾¢ÃñÎÅ¢Øõ 
Å¨ÄÔÁ¢¸ ×¿¡üÈÁ¾¡ö Ôñ¼¾ñ½£÷ Å¢Øó¾¢ÕìÌõ 
À¢ÄÓï ¦ºöÐ ¿¡º¢Â¨¼ìÌõ À£É¢ºò¾¢ý Ì½Á¢Ð§Å. 
 
Cough with expectoration, sneezing, running nose, pain in the occipital region 
which persists throughout the days. 
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AS PER AATHMA RATCHAMIRTHAM 
º¢Ãº¢ø ¸É¦ÄØóÐ Ý¨ÄÂ¢ø §Ã¡¸õ 
«¾¢¸Ã¢òÐ º£ú§À¡Öõ º¢Ã¡ö §À¡Öõ 
¸¡½ôÀÎõ ´ÕÅ¢¾ ãìÌ §¿¡ö. 
 
Increased heat affects head causing pain and purulent discharge from the nose. 
 
NAGAMUNIVAR THALAI NOI MARUTHUVAM AND SIDDHAR ARUVAI 
MARUTHUVAM: 
 
¾¨ÄÁ¢¸ ÅÄ¢ìÌõ ¿¡º¢ ºÇ¢Å¢Ø¦Á¡Õ×ñ¼¡Ìõ 
¿Ä¢×Õ ÐõÁÖñ¼¡ý ¿¡ð¦ºÅ¢Â¢ø ÅÃÙõ¿¡º¢ 
Á¨Ä×Èò ¾¢ÃñÎ Å¢Øõ Å¡Ô§Å ¿¡¨ÇÓñ¼¡ø 
¦ÀÄÓÈ ãì¸¨¼ìÌõ À£É¢º ¦ÁýÚ §¾§Ã. 
 
¾¨ÄÔí ¸ÉòÐ ÅÄ¢¦¸¡ñÎ ºÇ¢§À¡É¡ º¡üÈ¢ÃñÎ Å¢Øõ 
«¨ÄÔ ¦Á¡Õô§À¡ ¦Ä¡Õ¸¡Ö ÁÚ¾¢ô À¼§Å Á¡È¡Ð 
Ì¨ÄÔí ¦¸¼¡Ð ÀÃ¢¸¡Ã ¿¢Â¾¢ôÀ¼§Å ¦ºöÐÅÃ¢ø 
¦¾¡¨ÄÔï ¦º¡ý§É¡õ À£É¢ºÓõ. 
 
 Severe headache 
 Rhinitis 
 Sneezing 
 Dryness of nose 
 Halistosis 
 Severe nasal block 
 Headache 
 Expectoration 
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AS PER AGASTHIYAR 2000 
¸ñ¼ Ó¸í¸¡ Ðí¸Ãí à÷ÅÐ §À¡Äò 
Ðñ¼Óó ¾¢É×õ Àò¾¢ ÐõÁ¢§Â ¾ñ½£÷ Å£úóÐ 
Áñ¨¼Ôí ¸ÉòÐ ¦¿¡óÐ Å¡¾Óõ À¨¸ì¸ÌÁ¡¸¢ø 
Óñ¼¸Á¾¢ìÌ Á¡§¾ ¿£÷À¡öîºÄ¡§Á.  
 Throat, ear and facial irritation 
 Itching in the nose 
 Rhinitis 
 Sneezing 
 Heaviness of head 
 Headache 
 
NOI NAADAL NOI MUDHAL NADAL PART-2 
 
 Itching and irritation in the nose results in rubbing the tip of the nose which 
becomes marked red, tense, tender. 
 Redness and lacrimation of eyes 
 Nasal obstruction 
 Itching and blockage of ears 
 Difficulty in breathing 
 Profuse watery discharge from the nose 
 headache 
AS PER AGASTHIYAR GUNAVAGADAM 
¾¨ÄÔí ¸ÉòÐ¦Å¡Õ ¿¡º¢ 
ºÇ¢Ôõ Å¢¨ÇóÐ ¦Å¡ÕôÀðÎ 
«¨ÄÔõ ¿¡§É ¦Âý¦º¡ýÉ¡ø 
«Ãñ§¼ Â¢Ú¸¢ò ¾¢ÃñÎÅ¢Øõ 
¯¨ÄÔ Á¢¸×õ ¿¡üÈÁ¾¡ö 
°¨¼ò ¾ñ½£÷ Å¢¨ÇóÐÅÕõ 
À¢ÄÓï §ºÃ ãì¸¨¼ì¸¢ø 
À£É¢º ¦ÁýÈ¡÷ ¦ÀÃ¢§Â¡§Ã.  – Agasthiyar Gunavagadam 
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AS PER THERAIYAR SEKARAPPA 
 
ãìÌ §¿¡Â¢ý ÀñÒ 
 
À£Éº Á¡É À¢½¢ì¸½ ¦ÁøÄ¡ 
Á¡É ¾¢Èò¨¾ Â¨Èó¾Ð §À¡¸ 
çÉÁ¢ Ä¡Ö¨Ãò¾ ÁÕó¨¾ 
¿¡ÉÅ¢ø ¸¢ýÈÉ ¿¡É¢ÄÁ£§¾ 
±ñÊÉ ÓüÈ Å¢ÃñÎ ¾Ãó¾¡ý 
ÀñÎÇ ¾¡ÌÁü Àí¸¢Éò¾¡Éó 
¾¢ñÊÈ §Ä¸¡Î ¦ºö¾¢ÈÄüÈ¡ý 
Áñ¨¼ ÅÈñÎ ÁÄ¢ó¾¢Î §¿¡§Â 
§¿¡ö¸¦Ç Ä¡Á¢Ð §¿¡¦ÂÉ Å¡Îõ 
§À¦ÂÉ Å¡ÊÂ À£É¢º§¿¡ö¸û 
º£ÂÈø §¸¡½¢¾ï º¢ðÊ¨Å ¿¡ýÌ 
§Á¡ö¾Ã ãì¨¸ ¦Â¡ÚìÌÁ¢¨¾Â¡ 
¸¡ö¾Ä¢Ä¡ô ¾¨¸ ¸ñ¼ºÅò¨¾ 
§Â¡¾Ä¢Ä¡¾¢¨¼ Ôñ¼ºÄò¾¡ø 
§Å¾Ä¢Ä¡ôÀ¢½¢ §Å¾¨ÉÂ¡ì¸¢ 
§À¾Ä¡¸¢Â À£É¢ºÁ¡§Á. 
 
Lack of taking oilbath twice in eight days leads to dryness in the head causing 
purulent, watery or blood discharge from nose and nasal block. Drinking unboiled 
water and contaminated water will cause peenisam.   
CLASSIFICATION 
 
As per Aathma ratchamirthamennum vaithiya saara sangiragam 
 
¸¡ôÀ¡É Å¡¾À£ É¢ºó¾¡É¡Ìõ 
¸Õ¾¢§Â §¸¡ ÃÂ¢ó¾ À£É¢ºÓÁ¡Ìõ 
Å¡ôÀ¡É º¢§ÄòÁÀ£ É¢ºÓÁ¡Ìõ 
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ÅÎò¾ ¿£÷ô À£É¢ºÁ¡õ º£ôÀ£É¢ºõ 
§ºôÀ¡É ×¾¢ÃÀ£ É¢ºÓÁ¡Ìõ 
¦ºÆ¢ôÀ¡É º¢È¡ô À£É¢º ãÄôÀ£É¢ºÁ¡õ 
¬ôÀ¡É ¸½À£É¢ºó¾¡ É¡Ìõ 
«ôÀÉ§É ¦ÂðÎ À¢ò ¾¢ñ½Á¡§Á. 
 
1.  Vaatha peenisam 
2. Pitha peenisam 
3. Silethma peenisam 
4. Ratha peenisam 
5. Seezh peenisam 
6. Neer peenisam 
7. Sirap peenisam 
8. Moola  peenisam 
According to Maruthuvam and noinadal noi mudhal nadal part 2 peenisam is of 9 
types. 
1. Vali peenisam 
2. Azhal peenisam 
3. Kapha peenisam 
4. Kuruthi peenisam 
5. Neer peenisam  
6. Seezh peenisam 
7. Sirai peenisam 
8. Mulai peenisam  
9. Kazhuthu peeenisam 
According to thanvandri vaithiyam  peenisam is of 10 types. 
1. Vatha peenisam  
2. Pitha peenisam 
3. Kapha penisam 
4. Vathapitha peenisam 
5. Vatha kapha peenisam 
6. Pithakapha peenisam 
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7. Mukutra peenisam 
8. Sala peenisam 
9. Ratha peenisam 
10. Varatchi peenisam. 
According to T.V sambasivam pillai maruthuva agarathi peenisam is of 7 types. 
1. Vatha peenisam 
2. Pitha peenisam 
3. Silethma peenisam 
4. Seezh peenisam 
5. Sirai peenisam 
6. Neer peenisam 
7. Ratha peenisam 
 
Mukutra vaerupadugal: 
 Due to food habits and deranged pitham i.e; pitham raised from its nature which 
body heat raises which inturn increases both vatham and kabam. 
 When doing yoga, the vitiated pitham along with udhana vayu reaches the head 
where it combines with kabam causes peenisam. 
NAADINADAIINPEENISAM 
Pithathil Sethuma Naadi:  
ÀñÀ¡É À¢ò¾ò¾¢ø §ºòÐÁ ¿¡Ê 
ÀÃ¢º¢ò¾¡ Äò¾¢ÍÃ Á¢¨ÇôÒ ®¨Ç 
¸ñ¸¡Ð ¿ÂÉÁÄõ ¿£ÕÁïºû 
¸ÉÅÂ¢Ú ¦À¡ÕÁø Áïºû§¿¡ö ¸ñ§É¡ö 
¯ñ§À¡Ð ÁÚò¾ø þÃò¾ Å¢ôÒÕ¾¢ ¾¡Ûõ 
¯¨ÇÁ¡ó¾ À£É¢ºÓõ þÃò¾ Å£ì¸õ 
¿ñÀ¡É ¸¡Á¡¨Ä §º¡¨¸ ¦ÅôÒ 
¿Ï¸¢Åó¾ ÀÄÀ¢½¢Ôõ ¿ñÏó¾¡§É    - Sathaga naadi 
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Sethumathil vaatha naadi: 
 
¸ñ¼¡§Â¡ º¢§ÄüÀÉò¾¢ø Å¡¾¿¡Ê 
¸Äó¾¢Î¸¢ø ÅÂ¢Ú ¦À¡ÕÁø ¸Éò¾ Å£ì¸õ 
¯ñ¼¡§Â¡ µí¸¡Ã ºò¾¢ Å¢ì¸ø 
¯Ú¾¢Ãð¨º Å¡ö×ÅÄ¢ ºó¾¢ §¾¡¼õ 
Å¢ñ¼¡§Ä þ¨ÇôÀ¢ÕÁø §º¡¨À À¡ñÎ 
Å¢¼À¡¸õ Å¢¼Ý¨Ä Àì¸Å¡¾õ 
¾¢ñ¼¡Î ¿¡º¢¸¡À£¼í ¸ì¸ø 
º¢Ã§¿¡ö¸û ÀÄ×õÅóÐ º¢ìÌó ¾¡§É.   - º¾¸ ¿¡Ê 
 
PINIYARI MURAIMAI 
 The method of diagnosis in siddha system based on, 
 Poriyalarithal 
 Pulanalarithal 
 Vinathal 
Porigal are considered as the five sense organs of perception namely nose, tongue, 
eye, skin and ear. 
Pulangal are five senses namely touch, smell, sound, taste and sight sensation. 
Physiciansuse their pori and pulan to examine the pori and pulan of the patient 
respectively to diagnose the disease. 
Vinathal is obtaining the information regarding the history of the diseases, the 
clinical features etc, from the patient or from immediate relatives who are taking care of 
him, when the patient is not in a position to speak or if the patient is child. 
 The above principle corresponds to the methodology of inspection, palpation, 
and interrogation methods of modernscience in arriving at a clinical diagnosis of the 
disease. 
 Siddha system of medicine has developed a unique method of diagnosing the 
disease is called “Envagai thervugal” 
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Envagai thervugal: 
1. NAADI 
The three uyirthathukal are formed by the combination  
 Edakalai   +  Abanan =Vaatham 
 Pinkalai    +  pranan =Pitham 
 Suzhumunai  +samanan = kabam 
In neer peenisam the following naadi are seen commonly 
1. Pitha kabham 
2. Pitha vaatham 
3. Kabha vaatham 
2. SPARISAM 
 In the case of neer peenisam, swelling of face is present. 
3. NAA 
 No abnormality was noted in the tongue of neer peenisam patients. 
4. NIRAM 
 In neer peenisam skin of the nose appears, reddish in colour due to over 
sneezing. 
5. MOZHI 
 In neer peenisam ,decreased resonance of voice due to nasal congestion. 
6. VIZHI 
 In neer peenisam patients, irritation of eyes, lacrimation and blurring of vision 
present. 
7. MALAM 
 No abnormality seen in stools. 
8. MOOTHIRAM 
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Neerkuri: 
The colour of urine of the neer peenisam patients ,was straw colour in general 
and in some cases it was yellow. 
Neikuri 
Prior to the day of urine examination for neikuri , the patients is adviced to take 
a balanced diet and the quantity of food must be proper for this appetite and patient 
should have a sound sleep. 
After waking up in the morning, urine is collected in a glass container and is 
subjected to analysis without disturbing its nature and the neikuri should be noticed in 
direct sunlight. 
Line of treatment: 
 In siddha system the main aim of the tratement is removal of udarpini and 
manapini. 
 Treatment is not only aimed removal of disease, but also for the preventing the 
disease and improving the immunity. 
This is said as follows: 
 Kaappu (Prevention) 
 Neekam (Treatment) 
 Niraivu (Restoration) 
The three humours which are responsible for organization, regulation and integration of 
the bodily structures and their physiological functions are always kept in a stage of 
equilibrium by word, thought, deed and food of the individual. The general aetiological 
factors for constitutional discomfort are said to be caused by incompatible diet, mental 
and physical activities. 
 So it is essential to know the disease and the cause for the onset of disease, the 
nature of the patient, the severity of illness, the seasons and time of the occurance of the 
diseases must be observed. 
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The line of treatment consist of, 
 Regulation of affected kutram 
 Drug for the disease 
 Diet restrictions 
In case of neer peenisam the medicines should be given to normalize the vitiated 
kapha and pitham. The ghee base medicines are given to reduce the vitiated pitham. 
DIET AND RESTRICTIONS: 
Diet should be taken: 
 Pepper 
 Karisalai 
 Thoothuvalai 
 Manathakkali 
 Murungai 
 Karunai 
 Nellikai 
Diet should be avoided: 
 Butter milk 
 Ice cream 
 Lemon juice 
Vegetables like, 
 Bottle gourd  
 Pumpkin 
 Snake gourd 
Advices to be followed: 
 Avoid polluted places and cold envirionment 
 Use hotwater for drinking and sanitary purpose. 
 Avoid sleeping during day time. 
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MODERN ASPECTS 
ANATOMY AND PHYSIOLOGY OF PARA NASAL SINUS 
 Paranasal sinuses are a group of air containing spaces that surround the nasal 
cavity. 
 
  
DEVELOPMENT 
 Maxillary and ethmoid sinuses are present at birth, while sphenoid sinus is 
rudimentary at birthand frontal sinus is recognizable at 6 years of age. 
Maxillary sinus 
 It appears an ectodermal depression above the uncinate ridge on inferior 
turbinate from where it starts expanding laterally and further grows due to spaces 
vacated by erupting teeth and by 25 years it is fully developed. 
Ethmoidal sinus 
 Small multiple ectodermal evaginations develop on lateral nasal wall and grow 
laterally into ethmoid bone. 
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Frontal sinus 
 It develops from frontal recess at the anterosuperior part of middle meatus 
which deepens gradually upwards. 
Sphenoid sinus  
 It appears as an ectodermal pit in posterosuperior aspect of nasal capsule and 
developes by invagination of mucosa of sphenoethmoidal recess. It is the first sinus to 
reach full size out of all paranasal sinuses. 
MAXILLARY SINUSES 
It is also called antrum of high more and is the largest sinus in the body of 
maxilla. It is sometimes referred as conductor of the orchestra. It is a pyramidal in 
shape, its apex directed laterally into the zygomatic process of maxilla and base 
forming lateral wall of Nose. 
DIMENSIONS 
 Height 33mm, width 23mm, anteroposteriorly 34mm and capacity varies from 
15 to 30 ml. 
IMPORTANT RELATIONS OF MAXILLARY SINUS  
ROOT 
 It is formed by floor of orbit traversed by infraorbital canal which transmits 
maxillary nerve and the vessel from behind forwards.  
FLOOR 
 It lies 1.25 cm below the nasal floor and is formed by alveolar process of 
maxilla related to 1
st
 premolar to 3
rd
 molar area.  
POSTERIOR WALL 
 Thin plate of bone separating the cavity from pterygopalatine and infratemporal 
fossa. 
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 Pterigopalatine fossa is a triangular space between maxilla, palatine and 
pterigoid process of sphenoid, and it contains internal maxillary artery vidian nerve and 
sphenopalatine ganglion. 
ANTERIOR WALL 
 It is formed by zygomatic process of maxilla, and medially by canine ridge. 
Infra orbital foramen is closely related to it. 
MEDIAL OR NASAL WALL 
 It is formed by nasal surface of maxilla below and in front. Perpendicular plate 
of palatine bone posteriorly, and uncinate process of ethmoid bone and descending part 
of lacrimal bone. Maxillary sinus ostia are 3 to 4 mm in diameter and are situated high 
up in posterolateral wall and opens in the middle meatus through ethmoidal 
infundibulam. 
 In 30% cases, accessory ostium is present which lies slightly posterior to the 
normal osteum. 
LINING OF MAXILLARY SINUS 
 Pseudostratified columnar ciliated epithelium which is quite thin and relatively 
less vascular thin with a few mucous glands. It is supplied by branches of maxillary, 
facial vein and pterygoid venous plexus. Lymphatics drain into submandibular lymph 
nodes. 
NERVE SUPPLY 
 It is by maxillary nerve through superior alveolar, anterior palatine and 
infraorbital nerve.secretomotor fibers relay through pterygopalatine ganglion. 
FRONTAL SINUSES 
 These are two in number and are of unequal size divided by a bony septum 
which is seldom in the midline. 
 Measurements are: Height 3.16 cm, breadth 2.58 cm and depth 1.8 cm. 
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 The sinus lies behind supercilliary arches and lies in a triangular area formed by 
nasion, a point 3 cm above nasion and the medial third of the supraorbital margin. 
 It opens into anterior part of middle meatus either through ethmoidal 
infundibulam or through frontonasal duct. 
IMPORTANT RELATIONS OF FRONTAL SINUS 
ANTERIOR WALL 
 About 1 to 5 mm thick and strong, formed by diploeic bone. 
POSTERIOR WALL 
 It is thin and formed by inner table which separates the sinus from anterior 
cranial fossa. 
FLOOR 
 It separates the frontal sinus from orbital cavity and slopes downwards towards 
the opening of frontonasal duct. Superiorly the sinus extends to a variable distance 
between the outer and inner tablets of the skull. 
Supraorbital artery, vein and nerve supply the sinus and lymphatic drainage is 
the submandibular lymph nodes. 
ETHMOIDAL SINUSES 
The number varies from 8 to 18, and these within the lateral part of ethmoid 
bone situated between the nasal cavity and the orbit giving it a honeycomb appearance 
called ethmoidal labyrinth. Each ethmoidal sinus has a pyramidal shape length is 4 to 5 
cm, height 2.5 cm, width is 1.5 cm decreasing anteriorly to 0.5 cm.  
 Ethmoidal sinuses are divided into two group‟s i.e. anterior smaller group 
consisting of agger cells, buller cells and frontal cells which open into upper part of 
hiatus semilunaris in the middle meatus, i.e. bulla ethmoidal also called middle 
ethmoidal groupof sinuses. 
Posterior group is larger. It opens into the superior miatus of nose. Optic nerve 
lies in close proximity to these cells. 
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IMPORTANT RELATIONS OF ETHMOIDAL SINUS 
ROOF 
 Roof of ethmoidal labyrinth is formed medially by cribriform plate but the main 
part of the roof is contributed by orbital plate of frontal bone with which ethmoid bone 
articulates. 
FLOOR OF INFERIOR WALL 
 It is formed anteriorly by orbital plate of maxilla posteriorly by orbital process 
of palatine bone and is related to maxillary sinus. 
LATERAL OR ORBITAL WALL 
 It is formed by lamina papyracea anteriorly.It is deficient and hence completed 
by lacrimal bone and posteriorly with lesser wing of sphenoid bone. Lamina papyracea 
also articulates inferiorly with maxillaand superiorly with the frontal bone.(This suture 
line is an important landmark as it indicates the roof of ethmoid sinuses in external 
ethmoidectomy) 
 It is formed by middle and superior turbinate bones. posteriorlyseparated from 
the sphenoid sinus by a thin bony septum. 
ARTERIAL SUPPLY 
 Anterior and posterior ethmoidal branches of ophthalmic and sphenopalatine 
artery. Venous drainage is to the corresponding veins. 
NERVE SUPPLY 
 It is by branches of maxillary nerve and ophthalmic nerve which form the 
anterior and posterior ethmoidal nerves. 
SPHENOID SINUSES 
 These are contained in the body of sphenoid bone and are situated in the 
posterior part of nasal cavity. These are rudimentary at birth but to grow after the third 
year. Its capacity varies from 0.5 to 30 ml with an average of 7.5 ml. 
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 Measurements are: height 2 cm, breadth 1.8 cm, and depth 2 cm. ostium lies in 
the upper part of anterior wall and opens into sphenoethmoidal recess. Bones of bertin 
also called sphenoidal turbinates initially cover the anterior wall of sinus, but after 10 
years fuse with it. 
IMPORTANT RELATIONS OF SPHENOIDAL SINUS 
ROOF 
 It is related with pituitary gland, and opticchiasma. Anterior roof is related to 
frontal lobe and olfactory tract. 
FLOOR 
It is related to roof of nasopharnyx and vidian nerve. 
ANTERIORLY  
 It is related to supraorbital fissure, 3
rd
, 4
th
 and 7
th
 cranial nerves and ophthalmic 
division of 5
th
 nerve. 
POSTERIORLY 
 Thick wall separates it from pons and basilar artery. 
LATERALLY 
 There is cavernous sinus, internal carotid artery and division of trigeminal 
nerve. 
BLOOD SUPPLY 
 It is by the posterior ethmoid and sphenopalatine artery. Veins drain into veins 
of nasal cavity. 
NERVE SUPPLY 
 It is by branches of sphenopalatine ganglion. 
LYMPHATICS 
 They go to retropharngeal lymphnodes. 
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FUNCTIONS OF PARANASAL SINUS 
Air conditioning, i.e. warming and moistening. 
Reduction of skull weight. 
Increases the olfactory area.(in animals) 
Heat insulation. 
Vocal resonance. 
Provides mechanical rigidity to skull. 
Pressure dampening. 
Secreation of mucous to keep nasal chambers moist. 
Absorption of shock to face and skull during injuries. 
Regulation of intranasal pressure. 
ACUTE SINUSITIS 
 It means acute infection or inflammation of the paranasal sinuses of less than 4 
weeks duration. It results once the normal defences of mucociliary blanket or 
lysozymes are breached by viruses and secondary invasion by bacteria takes 
place.pansinusitis is the term applied to inflammation of all the paranasal sinuses, 
whereas individual sinus involvement is named accordingly such as acute maxillary 
sinusitis, acute ethmoiditis, acute frontal sinusitis, acute sphenoiditis in order of 
occurance. 
 The sinus is said to be closed if the contained inflammatory exudates cannot 
escape because the viscosity of the exudates is high, or because the sinus ostium is 
closed. It is said to be open if ciliary action and overflow permit escape to the exudates 
from the sinus. 
AETIOLOGY 
INFECTIONS 
Nasal infections 
 Acute rhinitis associated with common cold spreads to the sinuses by way of 
their natural ostia which open into the nasal cavity. Foreign bodies in the nose may also 
set up acute rhinitis and further lead to sinusitis. 
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Pharyngeal infections 
Infections such as tonsillitis and adenoiditis may cause sinusitis in children. 
Tooth infections 
 The 1
st
 and 2
nd
 molar teeth are separated from maxillary sinus by a thin 
bone,and it may be absent in some cases,therefore chronic dental infections may spread 
either directly or through lymphatics. periodontal abcess which is an inflammation of  
the membrane which sorrounds the root of tooth and infection may spread either 
directly, by lymphatics or through blood stream. Sometimes tooth extraction may lead 
to infection of maxillary sinus, especially if fracture of tooth occurs during extraction, 
and it is forced into the antrum. 
Swimming and bathing  
 Swimming and bathing in infected ponds or pools, especially if jumping feet 
down. Even if water is uncontaminated, chemical rhinitis and sinusitis may be sufficient 
to cause bacterial sinusitis. 
Trauma to the sinuses 
 Compound fracture of the sinuses. 
 Contusion of the sinuses. 
 Foreign bodies. 
 Barotraumas of the sinuses during flight travel, especially during the 
descent of aeroplanes. 
General diseases 
 Such as influenza, measles, whooping cough, and pneumonia may lead to 
sinusitis. 
Other contributing factors 
 Poor general environment. 
 Low resistance, especially in children with little immunity. 
 Undue exposure to crowded cities people. 
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 Anatomical obstructions such as deviated nasal septum, hypertrophied 
turbinates, enlarged bulla or enlarged adenoids. Infective and allergic 
conditions of the nose also lead to mucosal swellings causing obstructions of 
the natural ostia of the sinuses. Polyp and tumours also cause sinusitis. 
 Association with chest conditions, e.g. chronic bronchitis, asthma, 
bronchiectasis and cystic fibrosis. Kartagener‟s syndrome include 
dextrocardia, chronic sinusitis and bronchiectasis and is due to faulty cilia. 
 Bacteriology 
Bacteria 
 Pneumonia (29%) 
 Streptococci 
 Staphylococci (6.6%) 
 H.influenzae (48%) 
 Escherichia coli 
 Micrococcus catarrhalis 
 Bacillus Pfeiffer 
 B.freidlander 
Viruses 
 Rhinovirus. 
 Parainfluenza 
 Enteric cytopathologic human orphan (ECHO) 28. 
 Coxsackie. 
 Respiratory syncital virus. 
Specific infections 
 Due to fungi, syphilis, tuberculosis and leprosy. 
Pathology 
 Sinusitis passes through five stages, i.e. catarrheal stage, exudative stage, 
suppurative stage of complications and stage of resolution. Inflammatory changes 
include hyperaemia with outpouring of serum and polymorphs associated with local 
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swelling, redness and oedema. If oedema persist for a longtime, cell degeneration with 
cloudy swelling and necrotic changes will occur. 
 Clinically, it may be catarrhal type or suppurative type. 
Acute catarrhal type 
 It is the earliest change in which there is oedema and mucous secretion with a 
few leucocytes but no destruction of mucous membrane. 
Acute suppurative type 
 There is severe inflammation with leucocytes and pus pouring out with necrosis 
of mucous membrane or it may become polypoidal. 
Clinical features 
General symptoms  
 Malaise 
 Headache 
 Fever 
 Sore throat 
 Facial pain 
 Periorbital oedema 
Local symptoms 
 Feeling of discomfort in postnasal space. 
 Nasal obstruction. 
 Loss of vocal resonance. 
 Lose of sense of smell. 
 Nasal or postnasal discharge or drip. 
 Cough 
 Pain in the sinuses. 
Antral pain 
 It is along the infraorbital margins and referred to upper teeth or gums on 
affected side. 
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Ethmoidal pain 
 It is localized over bridge of nose and inner canthus of eye and is referred to 
parietal eminence. 
Frontal sinus pain 
 It is localized to forehead and pain is periodical in natire, i.e. starts an hour or 
two after getting up from bed and vanishes during afternoon. 
Sphenoidal pain 
 It gives rise to occipital or vertical headache and sometimes is referred to 
mastoid process. Pain may be felt behind the eyeball due to close proximity with  5
th
 
nerve. 
Signs 
Anterior group 
 Maxillary, anterior ethmoidal and frontal. 
Posterior group 
 Posterior ethmoids and sphenoid. 
Anterior group drains into middle meatus, while posterior group drains into superior 
meatus and sphenoethmoidal recess. 
External signs 
 Flushing cheek with swelling of cheek which may spread to lower lid in 
maxillary sinusitis. Upper lid may be swollen in frontal sinusitis.  
 Ethmoiditis may give rise to swelling at the inner canthus of same eye. 
 Tenderness over the affected sinus. 
 Cheek:  maxillary sinusitis. 
 Floor of sinus:  frontal sinusitis. 
 Inner canthus:  ethmoids. 
 Anterior rhinoscopy red, shiny and swollen mucous membrane near the 
ostium of the sinus, and trickle of pus may also be seen. 
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Investigations 
 Haematology  -TLC and DLC are increased. 
 Culture sensitivity test for Nasal swab 
 Transillumination test. 
 Maxillary sinus- absence of infra orbital crescent of light papillary glow 
absence indicate sinusitis. 
 Frontal sinus- transillumination is not very informative. 
 X-ray PNS to demonstrate fluid level, pus or opacity. 
 CT scan –coronal CT may show thickening of mucosa or opacification with 
occlusion of maxillary infundibulam. 
Complications of acute sinusitis 
 Osteomyelitis of maxilla and frontal bone. 
 Orbital cellulitis. 
 Orbital abcess formation. 
 Intracranial complications like cavernous sinus thrombosis, meningitis, and 
intracranial abcess. 
 Chronic sinusitis. 
 Middle ear infection. 
 Pharngitis. 
 Laryngitis / tracheobronchitis. 
 Mucocele/pyocele 
 Oroantral fistula. 
CHRONIC SINUSITIS 
 It is one of the very commonly seen diseases of the sinuses. Maxillary sinus is 
most commonly involved. It usually follows acute sinusitis which has not been treated 
adequately or it may also follow a cold or tooth infection. It is a chronic inflammation 
of mucous membrane which has resulted in irreversible, usually degenerative, changes. 
Duration of symptoms is more than 3 months. 
AETIOLOGY 
 Chronic sinusitis follows acute sinusitis, chest conditions such as asthma, 
chronic bronchitis and chronic bronchiectasis may be responsible for chronic sinusitis. 
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FACTORS PREDISPOSING TO CHRONIC SINUSITIS 
 Anatomical deviated nasal septum  
 Kartagener‟s syndrome 
 Hypersensitivity 
 Dental sepsis 
 Poor resistance 
 Alcohol 
 dusty envirionment 
 Allergy subjects are more prone to secondary bacterial infections. 
Inflammatory products itself may act as allergens inducing further changes 
in the mucosa of nose and paranasal sinus.  
 Fungi also may be responsible for chronic sinusitis. 
 Iatrogenic factors- nasal packing, naso gastric or nasotracheal tubing. 
PATHOLOGY 
 Chronic sinusitis according to histological changes in the sinus mucosa may be 
as follows. 
HYPERTROPHIC SINUSITIS 
 In this, the inflammation mainly affects the efferent vesssels and 
lymphatics. Soft tissues are affected secondarily. Initially, there is 
periphlebitis and perilymphangitis. If repeated attacks occur, th e venous 
and lymphatic changes produce oedema and polypoidal mucous membrane, 
polypi, oedema of periosteum and rarefaction of bone.  
ATROPHIC SINUSITIS 
 The main change occurs in afferent vessels causing cellular reaction 
around the arterioles and arteries,  and later the vessel wall becomes 
thickened and narrowed resulting in endarteritis and thrombosis. In this 
condition usually there ismuch less edema. Both these types hypertrophic 
and atrophic may occur side by side in the same sinus producing atrophy at 
one place and polypoidal hypertrophy at a nearby place.  
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PAPILLARY OR HYPERTROPHIC SINUSITIS  
 Here occurs metaplasia of ciliated columnar epithelium to stratified squamous 
type and throughout the papillary hyperplastic epithelial cells or stroma may be seen 
inflammatory cells. It is a viral infection. 
FOLLICULAR TYPE 
 In this condition, small follicles are seen in the mucous membrane of the 
sinuses. 
GLANDULAR SINUSITIS 
 In this, the glandular elements increase markedly in the submucosal tissue 
linining of sinuses. 
CLINICAL FEATURES 
 There are two types of chronic sinusitis. 
SIMPLE CHRONIC INFECTIVE SINUSITIS 
 In this, vasomotor rhinitis and allergy are absent. It usually follows a single or  
repeated attacks of acute sinusitis. 
MIXED INFECTIVE AND VASOMOTOR CHRONIC SINUSITIS 
 The vasomotor factor is probably primary in most of these patients. A secondary 
infection results from chronic obstruction of ostium and polyposis or as a sequel of 
acute infection. 
FUNGAL SINUSITIS 
 Fungal infection occurs mostly in traumatic cases with compound fractures, in 
uncontrolled diabetics, depilated patients, such as carcinoma, and in patients on 
immunosuppressants, antibiotics or steroids. 
Types of fungal infections may be aspergillosis of sinus, actinomycosis which 
may result in granuloma of antrum or may be mucormycosis with mucor, rhizopus or 
absidia species of fungus. 
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 Presentation of fungal sinusitis may be in the form of allergic fungal sinusitis, 
invasive form, fungal ball or fulminant type of chronic fungal sinusitis. 
 Treatment may be surgery or antifungal therapy with or without steroids. 
CLINICAL FEATURES OF CHRONIC SINUSITIS 
NASAL SYMPTOMS 
 Nasal obstructions, nasal discharge and postnasal drip due to chronic rhinitis 
and hypertrophic mucosa of nose, especially the turbinates. The nature of 
nasal discharge depends upon the type of bacteria. 
 Postnasal drip is the commonest and most annoying symptom giving rise to 
dryness and burning at the back of nose together with an unpleasant taste in 
the mouth. 
 Epistaxis due to inflammatory vasodilators. 
 Smell abnormalities- cacosmia, hyposmia or parosmia. 
 Vestibulitis or excoriation of skin of nose may be present. 
PHARNGEAL SYMPTOMS 
 Pharyngitis 
 Dryness of throat 
 Tonsillitis 
 Lymphadenitis. 
EAR SYMPTOMS 
 Signs and symptoms of Eustachian tube obstruction or even otitis media. 
HEADACHE 
 Periodicity of headache is due to secretions accumulating in the sinuses during 
night and then draining away as the patient takes up erect posture. Different pain areas 
are noticed in involvement of various sinuses. 
EYE SYMPTOMS 
Conjunctivitis. 
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RESPIRATORY SYMOTOMS 
 Cough. 
 Hoarseness of voice. 
OTHER SYMPTOMS 
 Low grade gastritis with nausea. 
 General ill health and tiredness. 
 Fever off and on. 
SIGNS 
ANTERIOR RHINOSCOPY 
 It shows red swollen mucosa with pus in the middle meatus which can be made 
to appear by putting the head between the knees with infected sinus upward and then 
raising the head again. 
In ethmoiditis, the middle turbinate may be hypertrophied and polyp may be 
present. 
In sphenoid sinusitis, the pus may be seen in the olfactory cleft. 
POSTERIOR RHINOSCOPY 
 Pool of pus in the upper surface of palate indicates infection of anterior group of 
sinuses, and even pus at the posterior end of inferior turbinate is pathgnomic of anterior 
group of sinuses involvement. 
EXAMINATION OF PHARYNX 
 Pus may be seen in the lateral pharyngeal gutter,swelling of the lateral lymphoid 
tissue, but a trickle or curtain of pus in the posterior wall suggests infection of sphenoid 
or posterior ethmoidal cells. 
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INVESTIGATIONS 
Besides routine tests like Total Leucocyte count, Differential count, Eosinophil count, 
urine examination, and culture sensitivity of Paranasl discharge including examination 
for fungal cytology and Potassium hydroxide staining other investigations include the 
following. 
TRANSILLUMINATION TESTS 
 They are done for maxillary and frontal sinuses by a special torch in a darkened 
room. They are 15% less accurate than x-.rays. 
X-RAY EXAMINATION OF SINUSES 
 Occipitomental or water‟view. 
CT-SCAN OF NOSE 
 Especially osteomeatal complex. 
SINUS SOUNDING OR PUNCTURE OF THE SINUS 
 It is more appropriately carried out for maxillary sinus, sphenoid and ethmoidal 
sometimes. Remember for puncturing the sphenoid, anterior wall of sphenoid is 
situated at 7 cm from anterior nasal spine. Vomerine ridge on septum also leads to the 
rostrum of sphenoid crossing the centre of middle turbinate. 
DIAGNOSIS AND ASSESMENT 
 Signs and symptoms, proof puncture, and radiography rarely leave any doubt in 
diagnosis. Bacteriological state should be assessed. The presence of any predisposing 
factor, such as infected teeth, Deviated nasal septum and nasal polyp should be noted. 
Length of time of signs and symptoms and treatment taken in the past should be noted 
as these help to decide the future line of management of the case. 
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COMPLICATIONS OF CHRONIC SINUSITIS 
 Thrombophlebitis of diploeic veins leading to infection of the bone 
marrow. 
 Embolism 
 Perivascular lymphatics 
 Perineural sheath 
COMPLICATIONS OF ANTERIOR GROUP 
  Orbital complications, e.g. orbital cellulitis/abcess. 
 Mucocele/pyocele 
 Fistulae 
 Intracranial complications like thrombophlebitis, brain abcess, extradural 
abcess, and basal meningitis. 
 Osteomyelitis of bone 
 Pott‟s puffy tumor – described by sir pericivall  pott in 1760, it is 
doughy swelling of forehead due to osteomyelitis of frontal sinus which 
gives mouse eaten appearance on X-rays. 
COMPLICATIONS OF POSTERIOR GROUP 
 Superior orbital fissure syndrome /orbital apex syndrome 
 Cavernous sinus thrombophlebitis 
 Oroantral fistula /sublabial fistula.  
 Optic neuritis with impaired vision. 
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MATERIALS AND METHODS 
 
STANDARD OPERATING PROCEDURE FOR “SAMUTHRAPAZHA NEI”: 
Required raw drugs:  
I 
01. SAMUTHRA PAZHAM(Barringtonia acutanguala)-350 g(10 palam) 
02. INJI (Zingiber officinale,Rosc.)   -350 g (10 palam) 
03. VELLULLI (Allium sativum, Linn. )   -350 g (10 palam) 
II 
04. MURUNGAI VER(Moringa oleifera,Lam.)  -10.2g (2 kalanju) 
05. KODIVELI VER (Plumbago indica,Linn.)  -10.2g (2 kalanju) 
06. OMAM (Carum copticum, Benth&hook)  -10.2g (2 kalanju) 
07. INTHUPPU (Rock salt )    -10.2g (2 kalanju) 
08. CHUKKU(Zingiber officinale,Rosc) 
09. MILAGU(Piper nigram,Linn)    -10.2g (2 kalanju) 
10. THIPPILI (Piper longum ) 
11. KAYAM (Ferula asafoetida,Linn.)   -10.2g (2 kalanju) 
12. SEVVIYAM (Piper nigram,Linn.)   -10.2g 2 (kalanju) 
13. NAVACHARAM(Ammoni chloridum)  -10.2g (2 kalanju) 
14. KARUNCHEERAGAM(Nigella sativa,Linn.) -10.2g (2 kalanju) 
15. PULIYA MADAR KILANGU   -10.2g (2 kalanju) 
(PIRANDAI – Cissus quadrangularis) 
III 
16. GHEE       -2.6 lit (2 padi)  
SOURCE OF RAW DRUGS: 
                      The above said raw drugs will be purchased from a well reputed country 
shop at Chennai. The raw drugs will be authenticated by Botanist NIS, Pharmacognist 
SCRI Arumbakkam, Chennai. The raw drugs will be purified and the medicine will be 
prepared as per SOP as in the Gunapadam Laboratory of NIS, Chennai.  
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PURIFICATION OF TRIAL DRUGS: 
(Ref:      1. Deva Aasirvatham Samuel M.D(S), Marunthu sei iyalum kalaiyum, Indian 
medicine and Homeopathy, Chennai. 
2. Sigicharathana deepam,Kannusami pillai, first edition 2007.) 
1. Samuthra pazham (dry fruit of Barringtonia acutanguala) 
  Clean and Dry under shadow 
2. Inji (Rhizome of Zingiber officinale,Rosc.) 
 Peel the outer covering 
3.  Vellulli (Rhizome of Allium sativum, Linn) 
 Peel the outer covering 
4.  Murungai ver (Root of Moringa oleifera,Lam.) 
  Clean and Dry under shadow 
5. Kodiveli vaer(Root of Plumbago indica,Linn.) 
  Boil with cow milk and dry under shadow. 
6. Omam(Seed of Carum copticum, Benth&hook) 
 Soak in limestone water for 3 hours and dry 
7. Indhuppu(Rock salt ) 
 Soak in goat urine for 45 minutes and dry under sunlight.   
8. Chukku(Rhizome of Zingiber officinale,Rosc) 
 Peel the outer covering and Soak in limestone water and dry 
9. Milagu (Dry fruit of of Piper nigram,Linn)  
 Soak in amla juice and dry 
10. Thippili(Dry fruit of Piper longum ) 
 Soak in lemon juice and dry 
11. Kayam(Gum-resin  of Ferula asafoetida,Linn.) 
 Clean and fry gently 
12. Sevviyam(Root of Piper nigram,Linn)  
 Soak in amla juice and dry 
13. Navacharam(Ammonium chloridum) 
 Mix well with cow urine, filters it. Then boil and dry under sunlight.   
14. Karuncheeragam(Seed of Nigella sativa,Linn.) 
 Clean and Dry under sunlight for 6 hours and fry gently 
15. Puliyamadar kizhangu(Root tubers of PIRANDAI – Stem of Cissus 
quadrangularis): 
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Peel the outer covering and soak in butter milk for 3days and dry under 
sunlight. 
METHOD OF PREPARATION: 
Step 1: 
Ingredient I is boiled with 16.1 lit of water and reduced to 4 lit. 
Step 2: 
Ingredients II are ground and added to the above water mixture. Finally add 
ghee and boil till it reaches kudinei concistency (Sigicharathana deepam,Kannusami 
pillai, first edition 2007) as per siddha text. The prepared drug will be dispensed in 
sachets (64 ml each) once in 8days for 48 days. At each visit the patients will be 
advised to return the unconsumed drug if any.                                                                                      
SUBJECT SELECTION 
 As and when patients reporting at OPD of Department of Maruthuvam 
Ayothidass Pandithar Hospital with symptoms of inclusion criteria will be subjected to 
screening test & documented using screening proforma. 
INCLUSION CRITERIA 
 Age :18-50Yrs 
 Sex – Both male & female 
 The symptoms of pain in the face, purulent nasal discharge, and 
headache/heaviness of head, sneezing, fever, tooth ache, nasal block, and 
presence of any three symptoms will be taken as inclusion criteria. 
 Patient who are willing to sign the informed consent stating that he/she will 
conscientiously stick to the treatment during 24 days but can opt out of the trial 
of his/her own conscious discretion. 
 Patients who is willing for radiological investigation (X-ray for Paranasal 
sinuses) and provide blood, urine for lab investigation. 
EXCLUSION CRITERIA; 
 Bronchial asthma 
 Tuberculosis 
 Diabetes mellitus 
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 Hypertension 
 Pregnancy & Lactation 
 Heart disease     
 Chronic obstructive pulmonary disease 
WITHDRAWAL CRITERIA 
 Intolerance to the drug & development of adverse reactions 
during drug trial. 
 Poor patient compliance & defaulters. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Increase in severity of symptoms. 
TEST & ASSESSMENTS 
CLINICAL ASSESSMENT 
SIDDHA ASSESSMENT 
ROUTINE INVESTIGATION 
SPECIFIC INVESTIGATION 
Clinical Assessment:  
 1.  Sneezing    
 2.  Rhinorrhoea  
 3.  Headache/fasial pain 
 4. Nasal obstruction 
 5. Post nasal dripping 
 6. Fever 
 7. Heaviness of head while bending forward                                                   
 8. Tooth ache (most involving upper molar teeth) 
 9. Halitosis  
10. Lacrimation 
11.Nasal block 
12. Redness of eyes      
13. Burning sensation of nose 
14. Absence of taste. 
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SIDDHA ASSESSMENT: 
Thinai (Living Place) 
1. Kurinchi (Hill areas) 
2. Mullai (Forest) 
3. Marutham (Fertile land) 
4. Neithal (Costal area) 
5. Paalai (Desert) 
Paruva Kalam (season)  
1. Karkaalam (Aug 18 – Oct 17) 
2. Koothir kaalm (Oct 18 – Dec 16) 
3. Munpani kaalm (Dec 17 – Feb 12) 
4. Pinpani kaalam (Feb 13 – April 13) 
5. Ilavenil kaalam (April 14 – June 14) 
6. Muthuvenil kaalam (June 15 – Aug 17) 
Iymporikal: 
1. Mei (Skin) 
 
2. Vaai (Tongue) 
 
3. Kan (Eye) 
 
4. Mooku (Nose) 
 
5. Sevi (Ear) 
 
UYIRTHATHUKKAL: 
Vatham: 
1. Praanan 
2. Abaanan 
3. Samaanan 
4. Udhaanan 
5. Viyaanan 
6. Naagan 
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7. Koorman 
8. Kirukaran 
9. Dhananjeyan 
10. Devathathan  
Pitham: 
1. Anarpitham 
2. Prasakam 
3. Saathakam 
4. Aalosakam 
5. Ranjakam 
Kabam: 
1. Avalambagam 
2. Kilethagam 
3. Santhigam 
4. Tharpagam 
5. Pothagam 
En Vagai Thervu (Eight types of Examination): 
1. Nadi (Pulse perception) 
2. Naa (Tongue) 
3. Niram (Complexion) 
4.  Mozhi (Voice) 
5. Vizhi (Eyes) 
6. Sparisam (Palpatory perception) 
7. Malam (Bowel habits) 
8. Moothiram (Urine) Neerkuri& Neikuri 
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ROUTINE INVESTIGATION 
Haematology 
 Hb (gms%) 
 Total WBC Count(cells/cumm) 
 DC 
 Polymorphs(%) 
 Lymphocytes (%) 
 Eosinophils (%) 
 Monocytes (%) 
 Basophils (%) 
 Total RBC count (cells/cu.mm) 
 ESR(mm/hr) 
BLOOD BIOCHEMISTRY 
 Fasting and postparandial Blood sugar  
CLINICAL BIOCHEMISTRY 
Renal Function Test 
  Blood urea (mg/dl) 
 Sr. creatinine (mg/dl) 
 Uric acid (mg/dl) 
Lipid Profile 
 S. Total cholesterol (mg/dl) 
 HDL (mg/dl) 
 LDL  (mg/dl) 
 VLDL (mg/dl) 
 TGL (mg/dl) 
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Liver Function Test 
 S. Total bilirubin (mg/dl) 
 S. Direct bilirubin (mg/dl) 
 S. Indirect bilirubin (mg/dl)  
 SGOT (U/dl) 
 SGPT (U/dl) 
 S. Alkaline phosphatase (U/dl)  
 S. Total protein (g/dl) 
 S. Albumin (g/dl) 
 S. Globulin (g/dl) 
Other Test 
 S. Calcium (mg/dl) 
 S. Phosphorous (mg/dl) 
URINE EXAMINATION  
 Neerkuri and Neikuri 
 Albumin  
 Sugar (Fasting & postprandial) 
 Deposits  
SPUTUM - AFB 
Radiological Investigation 
X - Ray for Para nasal sinuses  
SPECIFIC INVESTIGATIONS 
1. Erythrocyte sedimentation rate (ESR) 
2. Absolute eosinophil count (AEC) 
STUDY ENROLLMENT  
 In this open clinical trial study, patients reporting at the OPD with the 
clinical symptoms of     sneezing, headache, running nose, nasal block, fever, tooth 
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pain, will be examined clinically will be enrolled in the study based on the inclusion 
and exclusion criteria. 
 The patients who are to be enrolled would be informed (Form IV) about 
the study, trial drug, possible outcomes and the objectives of the study in the language 
and terms understandable to them 
 After ascertaining the patient‟s willingness, informed consent would be 
obtained in writing from them in the consent form (Form IV A). 
 All these patients will be given unique registration card in which 
patient‟s registration number of the study, address, phone number and investigator‟s 
phone number etc. will be given, so as to report easily should any complication arise. 
 Complete clinical history, complaints and duration, examination 
findings-- all would be recorded in the prescribed Proforma in the history and clinical 
assessment forms separately. Screening Form- I will be filled up; Form I-A, Form –II 
and Form –III will be used for recording the patients‟ history, clinical examination of 
symptoms and signs and laboratory investigations respectively. 
 Patients would be advised to take the trial drug and appropriate dietary 
advice (Form IV-E) would be given according to the patients‟ perfect understanding 
CONDUCT OF THE STUDY: 
  The trial drug“SAMUTHRAPAZHA NEI” (Internal) will be given 
continuously for 48 days. For OP patients, they should visit the hospital once in 8 days. 
At each clinical visit clinical assessment is done and prognosis is noted. Laboratory 
investigations & radiological investigation will be done on the 0th day & 48th day of 
the trial. After the end of the treatment also, the patient is advised to visit the OPD for 
another 2months for follow-up. If any trial patient who fails to collect the trial drug on 
the prescribed day but wants to continue in the trial from the next day or two, he/ she 
will be allowed, but defaulters of one week and more will not be allowed to continue 
and be withdrawn from the study with fresh case being inducted. 
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DATA MANAGEMENT 
 After enrolling the patient in the study, a separate file for each patient 
will be opened and all forms will be filed in the file. Study No. and Patient No. will be 
entered on the top of file for easy identification. Whenever study patient visits OPD Br 
I during the study period, the respective patient file will be taken and necessary 
recordings will be made at the assessment form or other suitable form . The screening 
forms will be filed separately. 
 The Data recordings will be monitored for completion by HOD and 
adverse event by Pharmacovigilance Department of National Institute of Siddha. All 
forms will be further scrutinized in presence of Investigators and Sr.Research Officer 
(Statistics) for logical errors and incompleteness of data to avoid any bias. No 
modification in the results is permitted for unbiased reports. 
DATA ANALYSIS: 
 All collected data will be entered into the computer and manually cross checked 
the correctness of the data entry. The clinical symptoms and laboratory investigation of 
blood and urine will be analyzed by comparing the two point of data (before and after 
treatment) paired test and chi-square test will be employed to study the efficacy of 
treatment. Further the effect of co factors case, occupation, socio economic status, etc 
will be also be statistically analyzed. 
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OUTCOME: 
(i) Primary outcome: 
The outcome is mainly assessed by laboratory and clinical symptom scoring.
 
(ii)Secondary outcome: 
1. To collect and review the ideas mentioned in the ancient literature 
about the disease. 
2. To study other co factors related to the disease such as age, 
sex,occupation, family history, dietary habits, socio economic status, 
habituate etc on the disease 
3. To study the disease Neer peenisam on the basis of siddha like 
 Uyir thathukal 
Udal thathukal 
 Envagaithervu 
             4. To evaluate the biochemical analysis of the trial medicine. 
5.  To evaluate the physiochemical analysis of the trial medicine. 
6. To evaluate the In-vitro Anti inflammatory activity by protein (Albumin) 
denaturation assay of the trial medicine 
 
 
52 
 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
 If the trial patient develops any adverse reaction, he/she would be 
immediately referred to pharmacovigilance Department of NIS, and proper 
management will be given in OPD of National institute of siddha. 
 ETHICAL ISSUES 
1. To prevent any infection, while collecting blood sample from the patient,   
only disposable syringes, disposable gloves, with proper sterilization of lab 
equipments will be used.                         
2. No other external or internal medicines other than the trial drugs will be used. 
There will be no infringement on the rights of patient.    
3. The data collected from the patient will be kept confidentially. The patient 
will be informed about the diagnosis, treatment and follow-up.  
4. Aftergetting the consent from the patient (through consent form) they will be 
enrolled in the study.  
5. Informed consent will be obtained from the patient explaining in the 
understandable language to the patient. 
6. Treatment would be provided free of cost.  
   7. In conditions of treatment failure, adverse reactions, patients will be given   
alternative treatment at the National Institute of Siddha with full care throughout 
the end.                                                    
   8.The patients who are excluded (as per the exclusion criteria) are given 
proper treatment in Ayothidoss Pandithar Hospital, National institute of siddha. 
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DATA COLLECTIONS FORM 
 FORM I  SCREENING AND SELECTION PROFORMA 
 FORM II   CLINICAL RESEARCH FORM 
 FORM lll   LABORATORY INVESTIGATION ON ENROLLMENT  
AND CONCLUSION OF TRIAL 
 FORM  IV   DRUG COMPLIANCE FORM  
 FORM V   PATIENT INFORMATION SHEET  
 FORM  VI   PATIENT CONSENT FORM 
 FORM  VII  WITHDRAWAL FORM / ADVERSE REACTION FORM  
/   PHARMACOVIGILENCE FORM 
 FORM  VIII   DIETARY ADVICE FORM 
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DRUG REVIEW 
SAMUTHRA PAZHAM 
Botanical Name :Barringtonia acutangula,Linn. 
Sanskrit name  :Hijjal, vidula,and Ambuj. 
English name  :Fresh water mangrove, itchytree, and mango-pine, fish killer 
tree,  
Tamil name  :samuthra pazham. 
Other names  : Thathri pala, kadambu, Indian oak,  
Family   : Lecythidaceae. 
Parts used          :Dry fruit. 
Actions   : Anti pyretic, Anthelmintic, Expectorant, Analgesic, Anti 
inflammatory. 
Taste     :sweet, sour and bitter.   
Potency    : Hot.    
Division    :pungent. 
Phytochemicals :Barringtogenol C, Barringtoside A, Barringtoside B & C 
 
GENERAL CHARACTER: 
«È¢ó¾¢Îõ Â¢¨ÇôÒ ¸¡Âõ «¼÷ÅÄ¢ ¿¡º¢¿£Õ 
ÀÈ¢ó¾¢Îõ ¯¾ÃÅ¡Ô ¿£Ã¢Æ¢× ÌýÁõ 
§º÷ó¾¢Îõ Áñ¨¼ §Ã¡¸õ À£É¢ºõ ¿¡º¢ôÒüÚ 
«Èó¾¢Îõ ºÓò¾¢Ã¡ôÀÆò¾¢ý ¾ý¨Á ¦ºö§Â.  –Pathartha guna 
chinthamani 
Medicinal uses: 
Research on this plant has reported a number of medicinal uses, including 
antitumor (Seed extract), anti biotic, inhibition growth oh Helicobacter pylori, anti-
nociceptive activity and antifungal activity. 
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 INJI 
Botanical name    : Zingiber officinale,Rosc. 
Sanskrit name      :  Adrakam 
English name       :  green ginger. 
Tamil name         :  Inji 
Other names        :  Allam, Aarthragam, Aathiragam, Illakkottai, Narumarupu mathil. 
Family                  :  Zingiberaceae 
Parts used            :  Rhizome 
Actions        :Carminative, Stimulant, Anti inflammatory, Analgesic,                                                    
          Immuno modulatory,  Anti viral, Anti bacterial. 
Taste        :Pungent   
Potency       :Hot   
Division   :pungent 
GENERAL CHARACTER: 
þïº¢ì ¸¢íÌì ¸¢ÕÁøÂõ ´ì¸¡ûõ  
Åïº¢ìÌï ºýÉ¢ÍÃõ Åý§À¾¢-Å¢ïÍ¸¢ýÈ 
Ý¨ÄÂÚõ Å¡¾õ§À¡ó àñ¼¡¾ ¾£ÀÉÁ¡õ 
§Å¨ÄÔÚí ¸ñ½¡ö-Å¢ÇõÒ. 
                         («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
µÐ§Á þÕÁø ºýÉ¢ ¯Ú§º÷ôÀõ º÷ò¾¢ø åð¨º 
Å¡Ð¦ºö Å¡¾Ý¨Ä ÅÇ÷ó¾¢Îõ ¸Àõ þ¨ÇôÒ 
¿£¾Á¡õ «º¾¢ À¢ò¾õ §º¡¨¸Ôõ À¡ñÎ À£Ä¢ 
§À¾Á¡õ Å¡ö× §¿¡ö¸û ¦ÀÂÕõ þïº¢ ¾ýÉ¡ø ±ý§È. 
                                  (¦À¡ÕðÀñÒ áø) 
Medicinal uses: 
 It cures cold, cough, headache,asthma,kabha diseases, dyspepsia and digestion. 
 The ethanol extract of rhizome of ginger produced significantly inhibition of the 
carrageenan-induced rat paw edema and a reduction in the number of writhing 
induced by acetic-acid in mice. It posses anti inflammatory and analgesic 
activity. 
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 Ginger has been found to suppress prostaglandin synthesis through inhibition of 
cyclo-oxigenase 1 and 2. 
 Ginger also possess immune modulatory effects and is an effective antiviral and 
antibacterial activity. 
VELLULI 
Botanical name      :  Allium sativum.Linn 
Sanskrit name        :  Lesuna 
English name         :  Garlic 
Tamil name            :  poondu 
Other names           :  Lasunam, Kaayam, Ulli, Vellaipoondu, velvengayam. 
Family                    : Lilliaceae 
Parts used               :  Rhizome 
Actions                : Expectorant, Anthelmintic, Carminative, Tonic, Hepatoprotective, 
Anti diabetic, Anti tubercular, Anti bacterial, Anti atherosclerotic, Hypocholestremic, 
Anti carcinogenic. 
Taste   :Pungent   
Potency  :Hot   
Division  :Pungent 
Phytochemicals: Diallyl mono,di,tri, tetra,penta,hexa,hepta sulfides.Vinylthiins and 
ajoenes. 
GENERAL CHARACTER: 
ºýÉ¢¦Â¡Î Å¡¾ó ¾¨Ä§¿¡× ¾¡ûÅÄ¢ 
ÁýÉ¢ÅÕ ¿£÷§¸¡¨Å Åýº£¾õ_«ýÉ§Á 
¯ûÙûÇ¢ ¸ñÀ¡ö ¯¨ÇãÄ §Ã¡¸Óõ §À¡õ 
¦ÅûÙûÇ¢ ¾ýÉ¡ø ¦ÅÕñÎ. 
                          («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
¯¨Ã¦ÂÉ ¦Åû¨ÇâñÎ ¯Ú¾¨ÄÅÄ¢ Å¡öâðÎ 
¿¢¨Ã¦ÂÉ Å¡¾õ º£¾õ ¿¢ýÈ ¿£÷§¸¡¨Å ºýÉ¢ 
Å¢¨ÃÂ¢ø ¬ó¾¢ÃÓõ ÌýÁõ ¦ÅÌ ¸Àõ ÌÚÌÚôÒ 
¾¨ÃÂ¢É¢ø ¦¸üÀò§¾¡÷ìÌõ ¾Ìì¸Óñ¼¡¦Áý§È, 
                           (¦À¡ÕðÀñÒ áø) 
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Medicinal uses: 
 Is the remedy for sanni,vatha diseases, headache, tetanus, rhinitis,chillness and 
haemoroids. 
 Allinin were found to possess hepato-protective activity. 
 Histopathological studies indicated retardative effect of garlic supplementation 
to cholesterol rich diet , on the development of atherosclerosis in rabbits. 
 In goats garlic showed hypocholestremic and anti atherosclerotic effects. 
 
`MURUNGAI VAER 
 
Botanical name : Morringa oleifera,Lam. 
Sanskrit name   : Sigru-valkalum 
English name   : Horse radish,Drum stick tree. 
Tamil name      : Murungai 
Other names     : Sikuru,kiranjam,kizhavee,sobanjanam. 
 Family           : Moringaceae  
Parts used        :  Root 
Actions    : Anti lithic,anti septic,carminative,anti spasmodic,anti 
    viral,anti inflammatory,anti bacterial, cardiac stimulant. 
Taste     : Bitter, Astringent, Sweet.  
 Potency   : Coolent    
 Division  : Sweet,pungent 
 
GENERAL CHARACTER: 
ÓÕí¨¸§Å÷ô Àð¨¼ìÌ ãÎ ¸Àò§¾¡ 
¦¼¡ÕïÌÈ¡î ºýÉ¢ÍÃõ µÎõ-«Õí¸É¸, 
Åð¨¼ô ¦À¡ÕÓ¨ÄÂ¡ö! Å¡ö¦Å¡ÎÅ¢ ¼í¸Ù§Áü 
Àð¨¼ìÌô §À¡§Á ÀÈóÐ.       -  («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 
Medicinal uses: 
 All parts of the tree used in the treatment of ascites, rheumatism, venomous 
bites and as cardiac and circulatory stimulants. 
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KODIVELI 
 
Botanical name       : Plumbago indica,Linn. 
Other names              : Chitira moolam, kodi vanni,akni,vasagam. 
Family                        :  Plumbaginaceae 
Parts used                   :  Root 
Actions  : Anti septic,Anti pyretic,Anti bacterial,Anti oxidant. 
Taste   :  Pungent 
 Potency  :  Hot  
Division  :  Pungent 
 
GENERAL CHARACTER: 
 
¸ðÊ Å¢Ã½í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒì 
¸ðÊîÝ¨Ä Å£ì¸í ¸¡úãÄõ-ÓðÊÃò¾ì 
¸ðÎ¿£ §ÃüÈí ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
«ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ. 
                     («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
Medicinal uses: 
 It cures skin diseases, edema,piles, dyspepsia and ascites. 
 Plumbagin is a crystallinesubstance present in plumbago zeylanica. 
 Plumbagin showed regression of experimental tumor. Antimitotic,antifungal 
and antibacterial activities of plumbagin were reported. 
 The methanol extract of root of plumbagin are effective against acute 
inflammation. 
 Plumbagin possess anti inflammatory,cyto-toxic and anti-allergic effects. 
 
OMAM 
 
Botanical name  :  Carum copticum Benth & Hook.     
Other names              : Asamotham, thipiyam 
Family                       : Apiaceae 
Parts used                 : Seeds 
60 
 
Actions                     : Anti septic, Anti spasmodic, Carminative. 
Taste             : Pungent              
Potency  : Hot            
Division  : Pungent 
 
GENERAL CHARACTER: 
 
º£¾ÍÃí ¸¡ºï ¦ºÃ¢Â¡Áó ¾õ¦À¡ÕÁø 
§À¾¢Â¢¨Ãî ºø¸ÎôÒ §ÀÃ¡Áõ-µ¾¢ÕÁø 
Àø¦Ä¡ÎÀø ãÄõ À¸Á¢¨Å§¿¡ ¦Âý¦ºÔ§Á¡? 
¦º¡ø¦Ä¡Î§À¡õ µÁ¦ÁÉî ¦º¡ø. 
                             («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
Medicinal uses: 
C.copticum extracts and essential oil are reported to have anti cholinergic effect, 
anti spasmodic, bronchodilator, anti-tussive, anxiolytic, analgesic, anti inflammatory, 
anti microbial, anti viral, anti oxidant properties. 
 
INDHUPPU 
 
Sodium chloride impura (Rock salt) 
Other names: Sainthavam, Sindhooram, Mathi koormai, Mathiuppu 
 
GENERAL CHARACTER: 
 
«‰¼Ìýப௄õ ப௄ó¾õ «Í÷ì¸ÃîÝ÷ º£¾À¢ò¾ó 
Ðð¼ þÂõ ¿¡Êப௃புñ §¾¡„í¸ñ-¦¸ð¼ÁÄí 
¸ðÎÅ¢¼ Å¢óÐô¨Àí ¸¡Á¢Â§¿¡ö Åý¸ÃôÀ¡ý 
Å¢ðÎÅ¢¼ Å¢óÐô¨À Å¢ý 
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Medicinal uses: 
 
 It is beneficial to treat 8 types of gunmam, indigestion,menorrhagia,chillness of 
the body,pitha&kapha diseases,constipation, sexually transmitted diseases and 
eczema. 
CHUKKU 
Botanical name : Zingiber officinale.Rosc. 
Sanskrit name  : Nagaram 
English name  : Dried ginger. 
Tamil name  : Chukku 
Other names  : Arukan,athagam,ubakullam,vidamoodiya amirtham. 
Family                : Zingiberaceae 
Parts used             : Rhizome 
Actions               : Carminative, Stimulant, stomachic. 
Taste        : Pungent   
Potency       : Hot   
Division               : Pungent 
GENERAL CHARACTER: 
Å¢ÕõÀ¢Îõ Ý¨Ä Áó¾õ Å¢Îõ «¾¢º¡Ãõ §À¾¢ 
þÕÁø ¦¿ï¦ºÃ¢ôÒ ãÄõ Å¡¾ ¿£÷§¾¡„õ ÌýÁõ 
«ÕõÀ¢Â À¡ñÎ ¾¨Ä§¿¡ö «Õ¸¢Îõ ±ýÚ ¦º¡øÖ 
«ÕÌ ¦¾¡ì¸º¾¢ Íì¸¡ø «¸ýÈ¢Îõ ±ýÈÅ¡§È. 
                              (¦À¡ÕðÀñÒ áø) 
Ý¨Ä Áó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô ÀõÁÆ¨Ä  
ãÄõ þ¨ÃôÀ¢ÕÁø ãìÌ¿£÷-Å¡Ä¸À 
§¾¡¼Á¾¢ º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò 
§¾¡¼õ ¬Áõ §À¡ìÌï ÍìÌ. 
                          («¸ò¾¢Â÷ Ì½Å¡¸¼õ)  
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Medicinal uses: 
 Dried ginger is used to cure throbbing pain, indigestion,heart 
burning,derangement of three humours,haemorroids,wheezing,nasal discharge. It 
controls kapha and maintance body heat. Pain in the ear,buccal cavity&head,pain in the 
viscera,lacrimation,bacillary dyscentry various types of ageusia, anorexia, 
contamination of blood with dropsy, pricking pain in the abdomen,fever with 
cold,shivering. 
MILAGU 
Botanical name    : Piper nigrum Linn. 
Sanskrit name      :  Maricha 
English name       :  Black pepper 
Tamil name          :  Milagu 
Other names         :  Kari, kaayam, kolagam, thirangal,malaiyali 
Family                  :  Piperaceae. 
Parts used             :  Dried unripe fruit. 
Actions                 : Acrid, carminative, Antiperiodic, stimulant, antidote. 
Taste        :  Acrid, pungent             
Potency       :  Hot         
Division               :  Pungent 
GENERTAL CHARACTER: 
º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ-µÐºýÉ¢ 
Â¡ºப௄ÀŠ ப௄¡Ãõ «¼ý§ப௄¸õ ¸¡ºப௄¢¨Å 
¿¡ºí ¸È¢Á¢Ç¸¢É¡ø. 
                   («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
§¸¡Ï¸¢ýÈ Àì¸ÅÄ¢ ÌöÂ×§Ã¡ ¸õÅ¡¾ 
§º¡½¢¾í¸ Øò¾¢üÌû §¾¡ýÚ§¿¡ö-¸¡½Ã¢Â 
¸¡Ð§¿¡ö Á¡¾÷ÌýÁí ¸¡Á¡¨Ä Áó¾¦ÁýÈ£÷ 
²Ð§¿¡ö ¸¡Â¢Õì¸¢ø ®íÌ. - (§¾Ãý Ì½Å¡¸¼õ) 
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Medicinal uses: 
 It is used in fever,piles, gastric ailments,asthma, anemia and sore throat. 
 Piperine has anti inflammatory activity against carrageenin-induced rat paw 
oedema, cotton pellet granuloma and croton oil induced granuloma pouch in 
animal modal. Piperine possess cyclooxygenase inhibitory activity. 
 Piper nigrum extract significantly increased the analgesic activity of 
diclofenacsodium and pentazocine. 
 The polysaccharide fractions of piper nigrum acts as immune enhancer. 
 Piperine possess anti allergic activity. 
 
THIPPILI 
Botanical name           :  Piper longum Linn 
Sanskrit name             : Pippali 
English name              :  Long pepper 
Tamil name                :   Thippili 
Other names               :  Aarkathi, kolagam, ambu, aathi marunthu 
Family                        :  Piperaceae 
Part used                    :   Dried unripe fruits. 
Actions                       :  Stimulant, carminative 
Taste    :  Pungent          
Potency  :  Hot           
Division  :  Sweet 
GENERTAL CHARACTER: 
¸ñÊ¼Â¢ÕÁø ÌýÁõ ¸À¦Á¡Î Â£¨Ç À¡ñÎ 
ÁñÊ¼ À£Ä¢ «§Ã¡º¢Âõ ¾¨Ä§¿¡ö Å¡¾õ 
´ñÊÂ ÍÃÓò§¾¡„õ ÌÇ¢¦Ã¡Î ÅÄ¢Ôõ ப௄¡Úõ 
¾ñÊÂ ¾¡Ðñ¼¡Ìò ¾¢ôÀ¢Ä¢ Ì½Á¢¾¡§Á - (¦À¡ÕðÀñÒ áø) 
¬ºÉ§¿¡ö ¦¾¡ñ¨¼§¿¡ö ¬ÅÃ½ À¢ò¾Ó¾ø 
¿¡º¢Å¢Æ¢ ¸¡¾¢¨Å§¿¡ö ¿¡ðÒØ§¿¡ö-Å£º¢ÎÅ¢ 
Âí¸Ä¡ïº Éïº¢¨¾Ôõ «õÀ¡ö «Æ¢Å¢óÐõ 
¦À¡í¸Ä¡ïº ¿í¨¸Â÷§¸¡ð§À¡ø - (§¾Ãý Ì½Å¡¸¼õ) 
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Medicinal uses 
 It relieves cold,cough,asthma,hoarseness,diseases of nose,eye and ear. 
 Piper longum posses anti-inflammatory,anti-bacterial and immune-stimulatory 
activity. 
 
PERUNGAYAM 
 
Botanical name            :  Ferula asafoetida 
Sanskrit name              : Hingu 
English name               : Asafoetida 
Tamil name                  : Perungayam 
Other names                 :  Athiyakiragam, hingu, kayam, santhunasam. 
Family                          :  Apiaceae 
Part used                       :  Gum resin 
Actions                       :  Antispasmodic, expectorant, laxative, 
     carminative, anthelmintic. 
Taste    :  Bitter               
Potency  :  Hot                 
Division  :  Pungent 
 
GENERTAL CHARACTER: 
 
 ¦º¡øÄ¢Îõ Å¢„õ ¸¢Õப௄¢ ப௄§¸¡¾Ãõ Ìýப௄õ §ºüÀÉõ 
¦ÅøÄ¢Îõ Àø§¿¡ö Áó¾õ Å¡¾Óõ ¦¿ïÍû §¿¡× 
«øÄ¢Îõ «Ä¸¢ø §¿¡×õ «¸ýÈ¢Îõ ¦¸üÀî Ý¨Ä 
¸øÄ¢Îõ ¦ÀÕí¸¡Âò¾¡ø ¦¸üÀÅ¡ö ¦ÅøÄ¡õ §À¡§Ä. 
                                  (¦À¡ÕðÀñÒ áø) 
Medicinal uses: 
Asafoetida is used for the cure of asthma,diarrhea,skin diseases and . 
 Extracts of asafoetida are used as an antispasmodic,diuretic, vermifuge and an 
anti allergic. 
 Asafoetida possess anti-mutagenic and anti-cancer properties. 
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SEVIYAM 
Botanical name            :  Piper nigrum  
Sanskrit name  :  Maricha 
English name   :  Black pepper root 
 
Tamil name   :  Milagin vaer 
 
Other names  :  Kandeerai,saviyam,savikai 
 
Family   : Piperaceae. 
 
Part uses  :  Root 
 
Actions   :  Carminative, anti-periodic 
 
Taste   :  Acrid,pungent  
 
Potency   :  Hot  
 
Division  :  Pungent 
 
GENERTAL CHARACTER: 
Ý¨Ä «Õ¸¢ºýÉ¢ ¦¾¡øÄ¢ÕÁø ®¨ÇÀ¢ò¾õ 
§Á¨Äì ÌÃü¸õÁø ¦Åí¸Ç§¿¡ö-ãÄÍÃõ 
¸ùÅ¢Âí¸ò §¾Ú ¸É¾¡ ÅÃÅ¢¼Óï 
¦ºùÅ¢Âí ¦¸¡ûÇÅ¢Îó §¾÷. -  («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 
Medicinal uses  
 It is used in fever,piles, gastric ailments,asthma, anemia and sore throat. 
 Piperine has anti inflammatory activity against carrageenin-induced rat paw 
oedema, cotton pellet granuloma and croton oil induced granuloma pouch in 
animal modal. Piperine possess cyclooxygenase inhibitory activity. 
 Piper nigrum extract significantly increased the analgesic activity of 
diclofenacsodium and pentazocine. 
 The polysaccharide fractions of piper nigrum acts as immune enhancer. 
 Piperine possess anti allergic activity. 
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NAVACHARAM 
Scientific name :  Ammonium chloridum 
Tamil name       : Navacharam 
Other names     :  Ishtigai,saligai,suligai,padu. 
Actions          :  Expectorant, Diuretic 
Taste    :  Sour and bitter. 
GENERTAL CHARACTER: 
 
±ýÈ¢Îõ Ì¼ÖîÝ¨Ä þ¼Á§¸¡¾ÃÓõ ÌýÁõ 
¦ÅýÈ ¸øÄ¨¼ôÒ Å¡¾õ À£É¢ºõ Áñ¨¼§¿¡× 
ÐýÉ¢Â ºýÉ¢ ã÷î¨º ¾¢Ã¢§¾¡„õ ãì¸¨¼ôÒ 
¿ýÚ ¸üÈ¡¨Ç ¿¡üÈõ ¿Å¡îº¡Ãõ ¦¸¡ûÇô§À¡§Á.-(¦À¡ÕðÀñÒ áø) 
ÌýÁí Ì¼üÝ¨Ä ¦º¡øÖõ Á§¸¡¾Ãò¨¾  
Åý¨ÁÔÚí ¸øÄ¨¼ô¨À Á¡üÚí¸¡ñ-¸ýÁì 
¸Å¢îÍÓò §¾¡„í ¸ÉÅ¡¾õ ¿£ìÌõ 
¿Å¡îº¡Ãõ Á¡§¾ ¿Å¢ø.-  («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
Medicinal uses: 
 Navacharam is the remedy for gunmam,throbbing pain,ascites,renal calculai. 
 It also neutralizes three humours. 
 
KARUNCHEERAGAM 
SBotanical name  :  Nigella sativa.Linn 
Sanskrit name             :  Upakunchika 
English name  :  Black cumin, small fennel 
 
Other names  :  Aranam, upakunjikai 
Family   :  Rananunculacae 
Part uses   :  Seeds 
Actions   :  Carminative, diuretic, anthelmintic, parasticide. 
Taste    :  Bitter     
Potency   :  Hot     
Division  :  Pungent 
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GENERAL CHARACTER: 
¸Õïº£Ã¸ò¾¡ý ¸ÃôÀ¦É¡Î ÒñÏõ 
ÅÕïº¢Ã¡öô À£¿ºÓ Á¡üÚõ-«Õó¾¢É¡ø 
¸¡öîºø ¾¨ÄÅÄ¢Ôí ¸ñÅÄ¢Ôõ §À¡ÓÄ¸¢ø 
Å¡öîº ÁÕó¦¾É§Å ¨Å. - («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
GENERAL CHARACTER: 
§À¡¾§Å ¾¡Ðñ¼¡Ìõ ¦À¡ÕóÐ À£É¢ºõÒñ ¸¡öîºø 
¿£¾Á¡õ ¸ÃôÀ¡ý Áñ¨¼ §¿¡¦Å¡Î ¸ñ§¿¡ö Á¡Úõ 
º£¾Óõ ÅÄ¢¸û Å¢„õ º¢Èப௃புÈ µÊப௃§À¡Ìõ 
Á¡¾÷¸û º¢ÍÅÇÕõ Á¾¢ ¸Õïº£Ã¸ò¾¡ø. - (¦À¡ÕðÀñÒ áø) 
Medicinal uses: 
 Black cumin used in the treatment of liver ailments, anaemia, ascites, piles, 
indigestion, spermatorrhoea and dropsy. 
 Black cumin extracts was found to show Anti cancer activity. 
 Alcoholic extracts of the seed oil showed antibacterial, broncho-dilatory, hypo-
tensive and immune-stimulant activity. 
 
PIRANDAI 
Botanical name  :  Cissus quadrangularis.Linn 
Sanskrit name  :   Asthisamhari 
Tamil name   :  Pirandai 
Other names   :  Vachiravalli 
 
Family   :  Vitaceae 
 
Part used  :  Tuber 
 
Actions  : Alterative, Emmenagogue, Stomachic.  
 
Taste    :  Pungent 
 
Potency   :  Hot     
 
Division   :  Pungent 
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GENERAL CHARACTER: 
 
À¢Ãñ¨¼¨Â ¦¿öÂ¡øÅÚòÐô À¢ýÉ¨ÃòÐ Á¡§¾ 
¦ÅÕñÊ¼¡ §¾üÚ Å¢Øí¸¢ø-«ÃñÎÅÕõ 
ãÄò ¾¢ÉÅ¼íÌõ ãÄÅ¢ Ãò¾ÁÚõ 
»¡Äò¾¢ Ûû§Ç ¿Å¢ø - («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 
Medicinal uses: 
 The plant which has been proved to be highly effective in alleviating pain, 
reducing swelling and promoting healing of the simple fractures as well as 
associated disorders. 
 
 PASUNEI 
 
GENERAL CHARACTER: 
¾¡¸ ÓÆ¨Ä¸ð¸ï º÷ò¾¢À¢ò¾õ Å¡ÔÀ¢Ã 
§Á¸õ ÅÂ¢ü¦ÈÃ¢× Å¢ì¸ÄÆø-Á¡¸¡ºí 
Ìýப௄õ ÅÈðº¢ Ì¼üபுÃð¼ ÄŠ¾¢¸ð¸ï 
¦º¡ýãÄõ §À¡ìÌ¿¢¨Ãò ÐôÒ. - (À¾¡÷ò¾ Ì½º¢ó¾¡Á½¢) 
 
Medicinal uses: 
Cow‟s ghee cures dryness, vomiting,derangement of pitha and vatha, 
gonorrhea,gastritis,hiccup,body heat,chronic cough,gastric ulcer,dryness of the body, 
vomiting sensation fever due to bony origin,anorectal diseases and abnormal peristaltic 
movements. 
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PIRANDAI      VELLULLI 
      
 NAVACHARAM     KARUNGEERAGAM 
 
  
 
 KODIVELI       OMAM 
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   MILAGU       MURUNGAI VER 
  
    INJI      INTHUPPU 
   
 
     SAMUTHRA PAZHAM         GHEE 
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CHUKKU      SEVIYAM 
  
 PERUNGAYAM   SAMUTHRA PAZHA NEI 
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RESULTS AND OBSERVATION 
 
Results of the study were observed with respect to the following criteria;  
1. Sex distribution 
2. Age distribution 
3. Occupation 
4. Family history 
5. Diet 
6. Kaalam 
7. Chronicity of illness 
8. Gunam  
9. Past history 
10. Triggering factor 
11. Thinai 
12. Paruva kaalam  
13. Gnanenthiriyam 
14. Kosangal 
15. Derangement of Vatham 
16. Derangement of Pitham 
17. Derangement of Kabam  
18. Derangement of udal thathukal 
19. Derangement of envagai thervugal 
20. Neerkkuri anlysis 
21.  Neikkuri analysis 
22. Clinical features distribution 
23.  Improvement after treatment 
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Gender distribution 
 
 
 
 
 
 
 
Figure 1 
  
Inference: 
Among 40 cases the prevalence of the disease was found to be higher in females (25 
cases, 62.5%). 
 
 
 
 
37.50%
62.50%
Gender distribution
Male
Female
Sl. No Sex No of Cases Percentage 
1 Male 15 37.5% 
2 Female 25 62.5% 
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Age Distribution: 
Sl. No Age 
No of 
Cases 
Percentage 
1 18-25 10 25% 
2 26-33 13 32.5% 
3 34-41 11 27.5% 
4 42-50 6 
15% 
 
 
     Fig No: 2 
 
 
Inference: 
        Among 40 cases the prevalence of disease was found to be higher among the age 
group of 26-33 (13 cases, 32.5%). 27.5% of cases were belongs to 34-41, 25% of cases 
were belongs to 18-25and 15% of cases were belongs to 42-50 age group. 
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AGE DISTRIBUTION
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Occupation 
 
 
 
 
 
 
 
 
 
 
Fig No: 3 
 
 
Inference:  
Among 40 patients, (45%) 18 cases were house wives, 5 cases (12.5%) were 
electricians and 4 cases (10%) were students and workers, 5% were IT profession, bank 
staff and jobless, 2.5% were Police, driver and driver.  
 
5.00%
5.00%
12.50%
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45.00%
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5.00%
10.00%
2.50%
2.50%
0.00% 20.00% 40.00% 60.00% 80.00% 100.00%
IT professional
Jobless
Electricians
Student
Housewife
Tailor
Bank Staff
Workers
Driver
Police
OCCUPATION
Sl. No Nature of Work 
No. of 
Cases 
Percentage 
1 IT Profession 2 5% 
2 Jobless 2 5% 
3 Electricians 5 12.5% 
4 Student 4 10% 
5 Housewife 18 45% 
6 Tailor 1 2.5% 
7 Bank Staff 2 5% 
8  Workers 4 10% 
9 Driver 1 2.5% 
10 Police 1 2.5 
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Family History: 
Sl. No Family history No of Cases Percentage 
1 Family History (+ve) 1 2.5% 
2 Family History (-ve) 39 97.5% 
 
 
 
Figure 4 
 
 
 
Inference: 
 Among 40 cases, 97.5% of patients do not have any family history. Only 
2.5% of patients had family history. 
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Family history
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Dietary Habits 
 
Sl. No Dietary Habits No of Cases Percentage 
1 Vegetarian 0 0% 
2 Non Vegetarian 40 100% 
      
 
 
 
Fig No: 5     
 
 
 
 
Inference:  
 Among the 40 cases, all of them were under Non-Vegetarian category.  
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Kaalam Distribution: 
  
 
 
 
 
Fig No: 6 
 
Inference:  
 Among 40 cases, 57.5% of patients were in vaatha kaalam (age up to 33 years). 
42.5% of patients were in Pithakaalam (age up to 34-66 years). 
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Chronicity of illness: 
Chronicity of illness No. of Cases Percentage 
Up to 1 Month 0 0% 
2- 6 Month 5 12.5% 
6-12 Month 1 2.5% 
12-18 Month 8 20% 
Above 18 Month 26 65% 
Total 40 100% 
 
 
Fig No: 7
 
 
 
Inference: 
 Among 40 cases, 65% patients had 18 months chronicity of illness, 20% of 
patients had 12-18 months chronicity, 12.5% of cases had 2-6 months chronicity and 
2.5% of patients had 6-12 months chronicity. 
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 Gunam (Quality and Characters) 
Sl. No Gunam No of Cases Percentage 
1 SathuvaGunam 0 0% 
2 RajoGunam 40 100% 
3 ThamoGunam 0 0% 
 
Inference: Among 40 cases, all of them had Raso gunam 
 
Past History of peenisam: 
 
Sl. No Past History No of Cases Percentage 
1 Past History of peenisam 14 35% 
2 No Past History of peenisam 26 65% 
 
Fig No: 8 
 
  
Inference:  
Among 40 cases, 65% of patients don‟t have any past history. Only 35% of 
cases had past history of Peenisam. 
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Past history of peenisam
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Triggering Factor: 
Sl. No Triggering Factor No. of Cases Percentage 
1 Dust 14 35% 
2 ColdExposure 24 60% 
3 Smoke 2 5% 
4 Total 40 100% 
 
 
 Fig No: 9 
 
 
 
Inference: 
 Among 40 cases, 60% of patients had cold exposure, 35% of patients had dust, 
5% of cases had smoke as triggering factors. 
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Thinai Reference: 
 
Sl. 
No 
Thinai No. of Cases Percentage 
1 Kurinji (Hill Area) 2 5% 
2 Mullai (Forest Area) 0 0% 
3 Marutham (Fertile Land) 12 30% 
4 Neithal (Coastal Area) 26 65% 
5 Paalai (Desert Land) 0 0% 
 
       
Fig No: 10 
 
  
 
Inference:  
 Among 40 cases, 65% of cases were belongs to Neithal nilam, 30% of cases 
belongs to Marutha nilam, 5% of cases were belongs to Kurinji nilam. 
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Paruvakalaam  
Season No of cases Percentage 
1. Kaar kaalam 0 0 
2. Koothir kaalam 0 0 
3. Munpani kaalam 24 60 
4. Pinpani kaalam 8 20 
5. Ilavenil kaalam 8 20 
6. Muthuvenil kaalam 0 0 
     
 
 Fig No: 11 
  
 
Inference:  
 Among 40 cases, 60% of patients were suffered in Munpanikaalam, 20% of 
patients were suffered in Pinpani kaalam and another 20% of cases were suffered in 
ilavvenil kaalam 
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Gnanendrium: 
Sl. No Gnanendrium No of Cases Percentage 
1. Mei 0 0% 
2. Vai 0 0% 
3. Kann 12 30% 
4. Mooku 40 100% 
5. Sevi 5 12.5% 
 
 
 
Fig No-12 
 
 
Inference:  
 Among 40 cases, all the patients had Nasal obstruction, temporary anosmia. 
30% of patients had Dullness of both eyes, 12.5% of patients had Ear obstruction.  
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Kosangal: 
Sl. No Kosangal 
Before treatment 
(%) 
After 
treatment (%) 
1. AnnamayaKosam 100% 20% 
2. PranamayaKosam 100% 20% 
3. ManomayaKosam 100% 10% 
4. VingnanamayaKosam 0% 0% 
5. AnandhamayaKosam 0% 0% 
 
 
Fig No-13 
 
 
 
Inference: 
 Among 40 cases, all of them were affected with Annamayakosam, Piranamaya 
kosam, and Manomaya kosam in before treatment. After treatment 20% of patients 
were affected with Annamaya kosam and piranamayakosam, and 10% of cases were 
affected with manomayakosam. 
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Vaatham 
 
Sl. No 
Classification of 
Vaatham 
Before 
treatment 
(%) 
After 
treatment (%) 
1 Praanan          100% 40% 
2 Abaanan 15% 5% 
3 Udhaanan 100% 20% 
4 Samaanan             100%           40% 
5 Viyaanan 10% 10% 
6 Naagan 0% 0% 
7 Koorman 25% 25% 
8 Kirukaran 100% 40% 
9 Devathaththan 100% 7.5% 
10 Dananjayan 0% 0% 
      
Fig No-14 
 
Inference: 
 Among 40 cases, before treatment all of them were affected with Piranan, 
Udhanan, Smaanan, Kirukaran and Devathathan, 15% of cases were affected with 
Abaanan, 10% of cases were affected with Viyanan, 25% of cases were affected with 
Koorman. 
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 After treatment, 40% of cases were affected with Piranan, Samaanan and 
Kirukaran, 20% of cases were affected with Udhanan, and 7.5% of cases were 
affected with Devathathan. 
 
Piththam 
 
Sl. 
No 
Classification of Pitham 
Before 
treatment 
(%) 
After 
treatment 
(%) 
1 Analpitham 0% 0% 
2 Ranjagapitham 0% 0% 
3              Sathagapitham 0% 0% 
4              Aalosagapitham 70% 20% 
5 prasagapitham 0% 0% 
       
Fig No: 15 
 
  
 
Inference:  
 Among 40 cases, 70% of patients were affected with Aalosaga pitham in 
before treatment. After treatment, only 20% of patients were affected with 
Aalosagaptham. 
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Kabam 
 
Sl. No Classification of Kabam 
Before 
treatment 
(%) 
After 
treatment 
(%) 
1 Avalambagam 65% 20% 
2 Kilethagam 0% 0% 
3 Pothagam 0% 0% 
4 Tharpagam 65% 20% 
5 Santhigam 0% 0% 
       
Fig No: 16 
   
 
Inference:  
 Among 40 cases, 65% of patients were affected with Avalambagam and 
Tharpagam in before treatment. After treatment it was affected in only 20% of patients. 
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UdalKattukkal 
 
Sl. No UdarKattukkl 
Before 
treatment 
(%) 
After 
treatment 
(%) 
1 Saaram 100% 20% 
2 Senneer 30% 30% 
3 Oon          0%          0% 
4 Kozhuppu 0% 0% 
5 Enbu 0% 0% 
6 Moolai 0% 0% 
7 Sukkilam/Suronitham 0% 0% 
      
Fig No: 17
 
 
Inference:  
 Among 40 cases, 100% of patients were affected with Saaram, 30% of patients 
were affected with Senneer in before treatment. After treatment 20% of patients were 
affected with Saaram. 
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EnvagaiThervu 
 
1 Envagaithervu 
Before treatment 
(%) 
After treatment 
(%) 
2 Naa 15% 2.5% 
3 Niram 0% 0% 
4 Mozhi          65%            20% 
5 Vizhi 30% 10% 
6 Malam 5% 0% 
7 Moothiram 0% 0% 
8 Sparisam 70% 10% 
   
Fig No: 18  
  
Inference:  
 Among 40 cases, 70% of patients were affected with Sparisam, 65% of patients 
were affected with Mozhi, 30% were affected with Vizhi, 15% were affected with 
Naaand 5% were affected with Malam in before treatment.  
After treatment 10%  of patients were affected with Sparisam and Vizhi, 20% 
were affected with Mozhi and 2.5% were affected with Naa.             
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Neerkkuri, Neikkuri: 
 
Sl. 
No 
Type of Test No. of Cases Percentage 
1 
Neerkkuri: 
“ Niram” - Pale yellow 
                -Dark yellow 
24 
16 
60% 
40% 
2 
Neikkuri: 
(Vaatham) “AravanaNeendal” 
 
8 
 
20% 
(Piththam)“AzhipolParaviyathu” 20 50% 
 
(Kabam) “Muththothuninrathu” 
 
12 30% 
Others 0 0% 
      
 
Fig No: 19 
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Clinical Features  
S.No 
           Clinical 
Features 
Before 
treatment 
(%) 
After 
treatment (%) 
1 Rhinorrhoea 100%           37.5% 
2 Nasal Obstruction 75% 10% 
3 Sneezing 100% 37.5% 
4 Headache 97.5%% 32.5% 
5 Facial pain 97.5%          32.5%            
6 Post Nasal Dripping           35% 0% 
 
 
Fig No: 20 
 
 
Inference:  
 Among 40 cases, 100% of patients had Rhinorrhoea and sneezing, 97.5% had 
Head ache and facial pain 75% of patients had Nasal obstruction, 35% of patients had 
Post nasal dripping in before treatment. 
 After treatment, 37.5% of patients had Rhinorrhoea and sneezing, 32.5% had 
head ache and facial pain and 10% had Nasal obstruction. 
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RESULT:  
Improvement after 
treatment 
GOOD MODERATE MILD POOR 
30% 50% 12.5% 7.5% 
 
 
 
 
Inference:  
 Among 40 cases, 30% of patients showed Good improvement, 50% showed 
Moderate improvement, 12.5% showed Mild improvement and 7.5% showed Poor 
improvement. 
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BLOOD INVESTIGATION (Haematology) 
S. 
NO 
OP NO NAME A/S 
TC 
Cells/cumm 
DC (%) 
P P L L M M E E 
    BT AT BT AT BT AT BT AT BT AT 
1 I57950 Arun joshi.S 30/m 8400 9000 62 60 32 31 - - 6 8 
2 I22078 Anitha.P 26/f 7600 8000 65 60 32 34 - - 3 6 
3 I47497 Muruga selvi. 24/f 7300 8200 54 52 41 40 5 0 - - 
4 G97302 Swarnalakshmi 21/f 8000 7900 60 60 34 36 6 4 - - 
5 I41877 Sinduja.S 27/f 6900 8200 63 64 33 32 - - 4 4 
6 I45501 Ellammal 41/f 8000 8400 55 54 37 38 3 5 - - 
7 I47469 Sarala.M 27/f 8300 7200 63 60 33 30 - - 4 8 
8 I39449 Jayanthi.s 40/f 10900 11300 56 55 38 41 2 4 4 - 
9 H46122 Lakshmisudha 36/f 5300 5600 46 50 47 40 0 0 7 10 
10 I46919 Vimalkumar.N 36/m 6000 6000 54 55 38 39 0 0 8 6 
11 I46798 Kavitha,S 28/f 7100 7400 52 50 40 38 0 0 8 10 
12 I42082 Kavitha.T 31/f 6200 7000 54 56 40 37 0 0 6 7 
13 I43334 Nanthini.N 24/f 7900 6400 48 51 48 44 0 0 4 5 
14 I44446 Parameshwari 33/f 8300 7900 69 68 25 25 1 0 5 7 
15 I38041 Manivannan.E 41/m 8400 6900 62 63 31 32 0 0 7 5 
16 I30933 Meena.R 27/f 8500 7200 60 62 30 30 0 0 9 5 
17 I39306 Hemavathy.N 41/f 8100 7200 59 56 37 41 - - - - 
18 I19082 Mahendran 30/m 8700 8400 61 65 34 29 5 6 - - 
19 H99884 Ganesh Shankar 24/m 10900 5100 78 53 18 41 - - 4 6 
20 I41510 Saroja.S 45/f 7600 7600 62 61 29 31 - - 9 8 
21 H77505 Thilagavathy.N 25/f 5700 5400 70 60 22 33 - - 8 7 
22 H95096 Parthiban.G 41/m 8000 8100 50 50 41 43 9 7 - - 
23 H05504 Mahalakshmi.G 18/f 6100 5100 73 60 18 32 9 8 - - 
24 I14630 Lalitha.R 48/f 7000 5200 54 50 40 44 6 6 - - 
25 I19581 Arumugam. 42/m 6800 8800 63 62 28 28 9 6 - - 
26 H96522 Lakshmi.N 35/f 4700 4600 49 50 45 41 5 9 - - 
27 H08542 Renuga.R 45/f 6500 6400 60 60 33 33 2 7 5 - 
28 I32663 Dinesh kumar 22/m 9000 8300 55 60 41 37 4 3 - - 
29 H95579 Giriprasad.R 35/m 6600 7800 51 60 42 33 0 0 7 7 
30 F012880 Devagi.K 49/f 5800 7900 50 50 43 45 - - 7 5 
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S. 
NO 
OP NO NAME A/S TC 
DC 
P P L L M M E E 
    BT AT BT AT BT AT BT AT BT AT 
31 H11925 Vetrivendhan.K 46/m 6100 7200 50 45 43 39 - - 7 6 
32 I12205 Gokulapriya .B 24/f 9200 8000 61 55 36 40 - - 3 5 
33 H38977 Kotteswari 41/f 9700 9300 59 60 37 35 0 0 3 5 
34 H94023 Shagul.M 32/m 9100 8200 62 60 30 30 0 0 8 5 
35 H83322 Thameemansari 18/m 5000 5500 55 58 41 40 0 0 4 1 
36 I58910 Alamelu.R 33/f 8500 8300 45 51 39 42 - - 12 5 
37 I58012 Logesh.B 20/m 6800 7800 50 60 38 34 2 6 10 - 
38 I44764 Vadivelu.n 30/m 5700 5900 55 61 33 33 0 0 8 6 
39 G69634 Loganayagi.D 30/f 8100 7900 55 55 40 42 0 0 5 3 
40 G86703 Loganathan. 37/m 7900 9700 59 70 35 25 6 5 - - 
 
Hemoglobin and Blood Sugar 
 
S. 
NO 
OP NO NAME A/S 
Hb 
gm/dl 
Bldsug(F) 
mgs% 
Bldsug(PP) 
mgs% 
BT AT BT AT BT AT 
1 I57950 Arun joshi.s 30/m 16.1 15.8 83 90 103 117 
2 I22078 Anitha.P 26/f 13.7 14.6 72 101 96 116 
3 I47497 Muruga selvi. 24/f 12.3 12.6 71 88 90 110 
4 G97302 Swarnalakshmi 21/f 13 12.1 70 100 74 114 
5 I41877 Sinduja.S 27/f 12.7 12.5 76 95 61 97 
6 I45501 Ellammal 41/f 12.7 12.5 74 102 73 110 
7 I47469 Sarala.M 27/f 10.1 10.3 81 90 77 102 
8 I39449 Jayanthi.s 40/f 13.3 12.8 82 104 101 111 
9 H46122 Lakshmisudha 36/f 8.9 9.6 66 102 69 104 
10 I46919 Vimalkumar.N 36/m 14.7 15.4 77 100 82 120 
11 I46798 Kavitha,S 28/f 10.9 10.1 77 102 97 163 
12 I42082 Kavitha.T 31/f 13.5 13.3 74 94 86 130 
13 I43334 Nanthini.N 24/f 13.6 13.3 63 100 74 111 
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14 I44446 Parameshwari 33/f 11.7 11.6 75 106 76 142 
15 I38041 Manivannan.E 41/m 16.4 16.3 78 97 127 111 
16 I30933 Meena.R 27/f 11.1 11.8 72 90 82 110 
17 I39306 Hemavathy.N 41/f 13.2 13.8 63 101 105 145 
18 I19082 Mahendran 30/m 15.5 15.5 101 86 127 105 
19 H99884 Ganesh Shankar 24/m 15.6 15.1 74 103 79 106 
20 I41510 Saroja.S 45/f 12.8 12.5 74 105 70 134 
21 H77505 Thilagavathy.N 25/f 9.6 9.1 74 94 78 102 
22 H95096 Parthiban.G 41/m 14.8 14.9 114 117 133 150 
23 H05504 Mahalakshmi.G 18/f 11.4 10.1 62 96 69 101 
24 I14630 Lalitha.R 48/f 14.3 13.7 65 91 100 95 
25 I19581 Arumugam. 42/m 15 15.4 93 110 144 180 
26 H96522 Lakshmi.N 35/f 10.2 10.4 77 98 110 102 
27 H08542 Renuga.R 45/f 13.4 12.2 81 92 70 97 
28 I32663 Dinesh kumar 22/m 15.3 14.6 80 83 110 152 
29 H95579 Giriprasad.R 35/m 15.6 15.1 97 93 110 100 
30 F012880 Devagi.K 49/f 12.6 12.5 96 96 145 160 
31 H11925 Vetrivendhan.K 46/m 14.8 15.2 99 119 108 120 
32 I12205 Gokulapriya .B 24/f 13 12.6 95 94 98 82 
33 H38977 Kotteswari 41/f 13.1 12.2 108 97 142 132 
34 H94023 Shagul.M 32/m 14 13.8 94 108 104 122 
35 H83322 Thameemansari 18/m 14.9 15.2 98 102 110 112 
36 I58910 Alamelu.R 33/f 9.7 9.9 92 87 122 120 
37 I58012 Logesh.B 20/m 15.7 14.9 98 96 143 128 
38 I44764 Vadivelu.n 30/m 11 12.7 72 86 96 110 
39 G69634 Loganayagi.D 30/f 13.4 12.8 99 110 122 116 
40 G86703 Loganathan. 37/m 15.1 13.9 76 99 88 110 
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URINE ANALYSIS 
S. 
NO 
OP NO NAME A/S 
URINE ANALYSIS 
Albumin Sugar 
Deposits 
Pus cells Epi cells 
    BT AT BT AT BT AT BT AT 
1 I57950 Arun joshi.s 30/m NIL NIL NIL NIL 2-4 1-2 1-2 1-2 
2 I22078 Anitha.p 26/f NIL NIL NIL NIL 6-8 6-7 6-8 2-4 
3 I47497 Murugaselvi. 24/f NIL NIL NIL NIL 2-4 1-2 2-4 2-4 
4 G97302 Swarnalakshmi. 21/f NIL NIL NIL NIL 2-4 2-3 2-4 2-3 
5 I41877 Sinduja.s 27/f NIL NIL NIL NIL 2-4 2-4 2-4 1-2 
6 I45501 Ellammal. 41/f NIL NIL NIL NIL 1-2 2-4 1-2 2-4 
7 I47469 Sarala.m 27/f NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
8 I39449 Jayanthi.s 40/f NIL NIL NIL NIL 1-2 2-4 1-2 2-4 
9 H46122 Lakshmisudha. 36/f NIL NIL NIL NIL 2-3 2-3 1-2 1-2 
10 I46919 Vimalkumar.N 36/f NIL NIL NIL NIL 1-2 3-5 2-4 3-5 
11 I46798 Kavitha.s 28/f NIL NIL NIL NIL 2-3 2-3 2-3 2-4 
12 I42082 Kavitha.T 31/f NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
13 I43334 Nanthini.N 24/f NIL NIL NIL NIL 2-4 2-4 2-4 2-4 
14 I44446 parameshwari 33/f NIL NIL NIL NIL 2-3 1-2 1-2 1-2 
15 I38041 Manivannan.E 41/m NIL NIL NIL NIL 2-3 3-5 2-3 3-5 
16 I30933 Meena.R 27/f NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
17 I39306 Hemavathy.N 41/f NIL NIL NIL NIL 3-5 2-4 2-4 2-4 
18 I19082 Mahendran 30/m NIL NIL NIL NIL 3-5 2-4 1-2 1-2 
19 H99884 Ganesh shankar 24/m NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
20 I41510 Saroja.S 45/f NIL NIL NIL NIL 2-4 1-2 1-2 1-3 
21 H77505 Thilagavathy.N 25/f NIL NIL NIL NIL - 1-2 - 2-4 
22 H95096 Parthiban.G 41/m NIL NIL NIL NIL 1-2 2-3 2-4 2-4 
23 H05504 Mahalakshmi.G 18/f NIL NIL NIL NIL 1-2 1-2 1-3 2-4 
24 I14630 Lalitha.R 48/f NIL NIL NIL NIL 1-2 3-5 2-4 2-4 
25 I19581 Arumugam. 42/m NIL NIL NIL NIL 2-3 3-5 2-3 1-2 
26 H96522 Lakshmi.N 35/f NIL NIL NIL NIL 2-3 1-2 2-3 1-2 
27 H08542 Renuga.R 45/f NIL NIL NIL NIL 2-4 2-3 2-4 1-2 
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28 I32663 Dinesh kumar 22/m NIL NIL NIL NIL 1-2 2-4 2-4 2-4 
29 H95779 Giriprasad .R 35/m NIL NIL NIL NIL 2-4 2-3 1-2 2-3 
30 F012880 Devagi.k 49/f NIL NIL NIL NIL 2-3 2-4 2-3 1-2 
31 H11925 Vetrivendhan.K 46/m NIL NIL NIL NIL 2-4 1-2 2-4 2-3 
32 I12205 Gokulapriya .B 24/f NIL NIL NIL NIL 2-4 1-2 2-4 1-2 
33 H38977 Kotteswari 41/f NIL NIL NIL NIL 2-4 1-3 6-8 2-4 
34 H94023 Shagul.M 32/m NIL NIL NIL NIL 1-2 1-2 1-2 2-4 
35 H83322 Thameemansari 18/m NIL NIL NIL NIL - - 1-2 2-4 
36 I58910 Alamelu.R 33/f NIL NIL NIL NIL 1-2 2-4 1-2 2-4 
37 I58012 Logesh.B 20/m NIL NIL NIL NIL 4-5 2-3 4-5 4-5 
38 I44764 Vadivelu.n 30/m NIL NIL NIL NIL 2-3 2-4 1-2 1-2 
39 G69634 Loganayagi.D 30/f NIL NIL NIL NIL 2-4 1-2 1-2 2-4 
40 G86703 Loganathan. 37/m NIL NIL NIL NIL 2-4 1-2 3-5 3-5 
 
Specific investigations : 
AEC and ESR before and after treatment : 
S. 
NO 
OP NO NAME 
AGE/ 
SEX 
AEC 
 
ESR 
BT 
 
AT 
BT AT 
½ 
hr 
1 hr 
½ 
hr 
1 hr 
1 I57950 Arun joshi.s 30/m 188 722 6 12 6 12 
2 I22078 Anitha.P 26/f 211 144 10 22 6 12 
3 I47497 Muruga selvi. 24/f 144 180 6 12 5 10 
4 G97302 Swarnalakshmi 21/f 270 188 6 12 2 6 
5 I41877 Sinduja.S 27/f 122 100 2 4 14 30 
6 I45501 Ellammal 41/f 244 100 6 12 4 10 
7 I47469 Sarala.M 27/f 191 211 8 18 6 12 
8 I39449 Jayanthi.s 40/f 422 188 42 82 24 52 
9 H46122 Lakshmisudha 36/f 200 166 34 70 16 32 
10 I46919 Vimalkumar.N 36/m 244 288 2 4 2 4 
11 I46798 Kavitha,S 28/f 288 1044 10 20 2 6 
12 I42082 Kavitha.T 31/f 188 322 12 24 10 20 
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13 I43334 Nanthini.N 24/f 144 200 16 32 12 24 
14 I44446 Parameshwari 33/f 355 366 20 42 24 90 
15 I38041 Manivannan.E 41/m 390 200 2 4 2 4 
16 I30933 Meena.R 27/f 711 580 4 8 8 16 
17 I39306 Hemavathy.N 41/f 166 44 42 84 32 64 
18 I19082 Mahendran 30/m 155 44 2 6 2 4 
19 H99884 Ganesh Shankar 24/m 299 166 2 4 2 4 
20 I41510 Saroja.S 45/f 288 400 24 50 24 50 
21 H77505 Thilagavathy.N 25/f 311 288 16 32 12 24 
22 H95096 Parthiban.G 41/m 188 160 6 12 2 4 
23 H05504 Mahalakshmi.G 18/f 254 133 10 22 2 6 
24 I14630 Lalitha.R 48/f 211 155 6 14 6 12 
25 I19581 Arumugam. 42/m 377 388 8 18 8 16 
26 H96522 Lakshmi.N 35/f 144 311 4 8 10 22 
27 H08542 Renuga.R 45/f 255 188 6 12 6 12 
28 I32663 Dinesh kumar 22/m 44 133 4 10 24 50 
29 H95579 Giriprasad.R 35/m 99 311 2 4 2 6 
30 F012880 Devagi.K 49/f 166 144 12 24 14 30 
31 H11925 Vetrivendhan.K 46/m 566 410 2 4 8 16 
32 I12205 Gokulapriya .B 24/f 66 144 12 24 10 20 
33 H38977 Kotteswari 41/f 299 188 20 42 30 60 
34 H94023 Shagul.M 32/m 88 144 22 46 12 8 
35 H83322 Thameemansari 18/m 144 102 2 4 8 16 
36 I58910 Alamelu.R 33/f 102 899 40 82 12 26 
37 I58012 Logesh.B 20/m 922 188 4 8 6 12 
38 I44764 Vadivelu.n 30/m 977 199 8 16 6 12 
39 G69634 Loganayagi.D 30/f 166 240 10 20 12 16 
40 G86703 Loganathan. 37/m 188 199 2 4 20 40 
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ANALYSIS OF TRIAL DRUG 
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CHEMICAL ANALYSIS 
Preparation of extract: 
25 ml of samuthra pazha nei is measured accurately and placed in a 250 ml of 
clean beaker and added with 50ml of distilled water. Then it is boiled well for about 10 
minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 
100ml with distilled water.  
S.NO  EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample Straw color  
I. Test For Acid Radicles   
1.  Test for Sulphate: 
2 ml of the above prepared extract is 
taken in a test tube to this added 2ml 
of 4% ammonium oxalate solution. 
No cloudy 
appearance. 
Absence of 
Sulphate. 
2. Test for Chloride: 
2 ml of the above prepared extract is 
added with dil. Hno3 till the 
effervescence ceases. Then 2 ml of 
silver nitrate solution is added. 
Cloudy appearance 
present. 
Presence of 
Chloride. 
3. Test for Phosphate: 
2ml of the extract is treated with 2ml 
of ammonium molybdate solution 
and 2ml of con.Hno3. 
No cloudy yellow 
appearance. 
Absence of 
Phosphate. 
4.  Test for Carbonate: 
2ml of the extract is treated with 2ml 
magnesium sulphate solution. 
Cloudy appearance 
present. 
Presence of 
Carbonate. 
5. Test for Nitrate:  
 1 drop of the substance is heated 
with copper turnics and concentrated 
H2SO4 and viewed the test tube 
vertically down.  
 
 
No characteristic 
changes. 
Absence of 
nitrate. 
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6. Test for Sulphide:  
1 ml of the substance is treated with 
2 ml of con.HCL. 
No rotten egg 
smelling gas 
evolved. 
Absence of 
Sulphide. 
7. Test for Fluride & Oxalate: 
2 ml of the extract is added with 2ml 
of dil. Acetic acid and 2 ml calcium 
chloride solution and heated. 
No cloudy 
appearance. 
Absence of 
Fluride and 
Oxalate. 
8. 
 
Test for Nitrite: 
3 drops of the extract is placed on 
filter paper on that 2 drops of acetic 
acid and 2 drops Benzidine solution 
is placed.  
No characteristic 
changes. 
Absence of 
Nitrite. 
9. Test for Borate:  
2 pinches of the substance is made 
into paste by using sulphuric acid 
and alcohol (95%) and introducer 
into the blue flame. 
Bluish green color 
flame not appeared. 
Absence of 
Borate. 
II. Test for Basic Radicles   
1. Test for Lead:  
2 ml of the extract is added with 2 ml 
of Potassium iodide solution. 
No yellow 
precipitate is 
obtained. 
Absence of Lead. 
2. Test for Copper: 
One pinch of substance is made into 
paste with con.HCL in a watch glass 
and introduced into the non- 
luminous part of the flame. 
No blue color flame. Absence of 
copper. 
3. Test for Aluminum:  
To the 2ml of the extract sodium 
hydroxide is added in drops to 
excess. 
No characteristic 
changes. 
Absence of 
Aluminium. 
4. Test for Iron: 
a. To the 2 ml of extract add 2 ml of 
ammonium thiocynate solution. 
Mild red color 
appeared. 
 
Presence of Iron. 
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b. To the 2ml of extract 2 ml 
ammonium thiocynate solution and 2 
ml of con.HNO3 is added. 
 
 
Blood red color 
appeared. 
 
 
Presence of Iron. 
5. Test for Zinc:  
To 2ml of the extract sodium 
hydroxide solution is added in drops 
to excess. 
White precipitate is 
not appeared. 
Absence of zinc. 
6. Test for Calcium: 
 2 ml of the extract is added with 2ml 
of 4% ammonium oxalate solution. 
No Cloudy 
appearance.  
Absence of 
Calcium. 
7. Test for Magnesium: 
To 2ml of extract sodium hydroxide 
solution is added in drops to excess.  
No white precipitate. Absence of 
magnesium. 
8. Test for Ammonium: 
To 2 ml of extract few ml of 
Nessler‟s reagent and excess of 
sodium hydroxide solution are added. 
No brown color 
appeared.  
Absence of 
ammonium. 
9. Test for Potassium: 
1 ml of substance is treated with 2ml 
of sodium nitrate solution and then 
treated with 2ml of cobalt nitrate in 
30% glacial acetic acid.  
Yellowish  
precipitate is 
obtained.  
Presence of 
potassium. 
10. Test for Sodium:  
2 pinches of the substance is made 
into paste by using HCL and 
introduced into the blue flame of 
Bunsen burner. 
No yellow color 
flame appeared. 
Absence of 
sodium. 
11. Test for Mercury: 
2 ml of the extract is treated with 2 
ml of sodium hydroxide solution. 
No yellow 
precipitate is 
appeared. 
Absence of 
mercury. 
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12. Test for Arsenic: 
  2 ml of the extract is treated with 2 
ml of sodium hydroxide solution. 
No brownish red 
precipitate is 
obtained. 
Absence of 
Arsenic. 
III. Miscellanious   
1. Test for Starch: 
2ml of the extract is treated with 
weak iodine solution. 
No blue color 
developed. 
Absence of 
starch. 
 
2. Test for Reducing sugar:  
5 ml of Benedict‟s qualitative 
solution is taken in a test tube and 
allowed to boil for two minutes and 
added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The 
color changes are noted. 
No brick red color 
developed. 
Absence of 
Reducing sugar. 
3. Test for the Alkaloids: 
2 ml of extract is treated with 2 ml of 
picric acid. 
Yellow color 
developed. 
Presence of 
Alkaloid. 
4. Test for Tannic acid:  
2 ml of extract is treated with 2 ml of 
ferric chloride solution. 
No Black color 
precipitate is 
obtained. 
Absence of tannic 
acid. 
5. Test for Unsaturated compound: 
To the 2 ml of extract 2 ml of 
Potassium permanganate solution is 
added. 
Potassium 
permanganate is not 
decolorized. 
Absence of 
Unsaturated 
compound. 
6. Test for Amino acid:  
2 drops of the extract is placed on a 
filter paper and dried well. 
No violet color 
developed. 
Absence of amino 
acid. 
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7. Test for Type of Compound: 
2 ml of the extract is treated 2 ml of 
ferric chloride solution.  
No green color 
developed. 
 
 
 
 
No red color 
developed. 
 
 
 
No violet color 
developed. 
 
 
No blue color 
developed. 
Absence of 
oxyquinole 
epinephrine and 
pyro catechol. 
 
 
Anti pyrine, 
Aliphatic amino 
acids and 
meconic acid are 
absent. 
Apomorphine 
salicylate and 
Resorcinol are 
absent. 
Morphine, Phenol 
cresol and hydro 
quinine are 
absent. 
 
 
Result:  
The chemical study of the trial drug reveals Chloride, Carbonate, Iron, 
potassium Alkaloid.  
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  Physicochemical evaluation of Samuthra pazha nei 
Project ID  : NRS/AS/0029/02/2017  
Institute  : National Institute of siddha ,Chennai 
Sample Name  : Samuthra Pazha Nei 
Sample ID   : SPN 
Percentage Loss on Drying 
10gm of test drug was accurately weighed in evaporating dish .The sample was dried at 
105oC for 5 hours and then weighed. 
Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 100 
Determination of Total Ash 
3 g  of test drug was accurately weighed in silica dish and incinerated at the furnace a 
temperature 400 ºC until it turns white in color which indicates absence of carbon. 
Percentage of total ash will be calculated with reference to the weight of air-dried drug. 
Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of pH 
Sample being oily in nature the direct litmus evaluation method was adopted to check 
the pH of the sample.  
Determination of Iodine value  
About 20 gm of SPN was transferred into Iodine flask. To which 10 ml of chloroform  
was added and warmed slightly and cooled for 10 minutes. Followed by this about 25 
ml of Wiji‟s solution was added in the same flask and shaken well. The flask was 
allowed to stand for 30 mins and refrigerated for an hour.T About 10 ml of KI solution 
was added to this and titrated against 0.1 N Sodium thiosulphate solutions until the 
appearance of yellow colour. 1 ml of starch indicator was added and again titrated 
against the sodium thiosulphate solution from the burette. Disappearance of blue colour 
indicates end point. Repeat the above procedure without taking sample and note the 
corresponding reading for blank titration. 
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Determination of saponification value  
About 2 gm of test sample was transferred into the round bottomed flask. To this about 
20 ml of 0.5 N alcoholic KOH solutions was added to the round bottomed flask. 
Repeatthe same procedure without taking the sample for blank titration . Reflux both 
sample and blank round bottomed flasks for 1 hour. After reflux, allow both the round 
bottomed flasks to cool. Titrate the samples using 0.5 N HCl with phenolphthalein 
indicator. The disappearance of pink indicates the end point.  
     
     Final Test report 
Parameter Observation 
Color Yellowish 
Smell Pleasant Chracteristic 
Touch Greasy 
 
S.No Parameter Mean (n=3) SD 
1 Loss on Drying at 105 °C (%) 16.7 ± 1.11 
2 Total Ash (%) 1.38 ± 0.13 
S.No Specific Test SPN 
1. pH 6 
 Refractive index 1.44 
 Iodoine value (mg I2/g) 125 
 Saponification Value  (mg of KOH to saponify 
1gm of fat) 
218 
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Reference:  
1. India Pharmacopeia I Volume I, Government of India, Ministry of Health and 
Family welfare, Indian Pharmacopeia commission, 2014. 
2. Pharmacopoeial Laboratory for Indian Medicine (PLIM) Guideline for 
standardization and evaluation of indian medicine which include drugs of  Ayurveda,  
Unani and  Siddha systems. Department AYUSH .Ministry of Health & Family 
Welfare, Govt. of India   
3. Indian standard methods of sampling and test for oils and fats Indian standard 
institution New Delhi 47-50. 1964 
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PHYTOCHEMICAL ANALYSIS OF SAMUTHIRA PAZHA NEI 
Sample Preparation 
Samuthra Pazha Nei (SPN) was extracted with hexane and the extract was subjected to 
the following analysis 
Test for Alkaloid- Mayer's reagent 
To the test drug about 2ml of Mayer's reagent was added and was observed for the 
presence of alkaloids. Appearance of dull white precipitate indicates the presence of 
alkaloids. 
Test for flavonoid 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were been added 
followed by addition of few drops of conc. Sulfuric acid. Appearance of yellow color 
indicates the presence of Flavonoids. 
Test for Glycosides - Borntrager‟s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water 
bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated 
and 10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
Test for Triterepnoids 
To the test solution 2ml chloroform was added with few drops of conc. Sulphuric acid 
(3ml) at the side of the test tube. An interface with a reddish brown coloration is formed 
if terpenoids constituent is present. 
Test for Steroids - Salkowski test 
To the test solution 2ml of chloroform was added with few drops of conc. Sulphuric 
acid (3ml), and shaken well. The upper layer in the test tube was turns into red and 
sulphuric acid layer  
Showed yellow with green fluorescence. It showed the presence of steroids. 
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Test for Carbohydrates - Benedict’s test 
To 0.5 ml of test drug about 0.5 ml of Benedic‟s reagent is added. The mixture is heated 
on a boiling water bath for 2 minutes. A characteristic coloured precipitate indicates the 
presence of sugar. 
Test – Phenol- Lead acetate test 
The test sample is dissolved in of distilled water and to this 3 ml of 10% lead acetate 
solution is added. A bulky white or creamy yellowish precipitate indicates the presence 
of phenolic compounds. 
Test for tannins  
About 0.5ml of test sample is boiled in 20 mL of distilled water in a test tube and then 
filtered. The filtration method used here is the normal method, which includes a conical 
flask and filter paper. The 0.1% FeCl3 is added to the filtered samples and observed for 
brownish green or a blue black coloration, which shows the presence of tannins 
Test for Saponins 
The test drugs were shaken with water vigorously for 10 mins , copious lather 
formation indicates the presence of saponins. 
Test for Proteins (Biuret Test) 
Biuret test: Equal volume of 5% solution of sodium hydroxide and 1% copper sulphate 
were added. Appearance of pink or purple colour indicates the presence of proteins and 
free amino acids. 
Test of Coumarins 
 1 ml of extract, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow color. 
Test for Quinones 
The test samples were treated separately with Alc. KOH solution. Appearance of colors 
ranging from red to blue indicates the presence of Quinones. 
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Test for Anthocyanin 
About 0.2 ml of the extract was weighed in separate test tube, 1ml of 2N Sodium 
hydroxide was added, and heated for 5 minutes at 100 ± 2°C. Observed for the 
formation of bluish green color which indicates the presence of anthocyanin. 
Test for Betacyanin 
To 2 ml of the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 
min at 100 Cᵒ.  Formation of yellow colour indicates the presence of betacyanin. 
Reference 
 Brain KR, Turner TD. The Practical Evaluation of Phytopharmaceuticals. 
Bristol: Wright- Scientechnica; 1975:36-45 
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PHYTOCOMPONENTS SPN 
ALKALOIDS + 
FLAVONOIDS + 
GLYCOSIDES + 
STEROIDS + 
SUGAR - 
TRITEREPNOIDS - 
COUMARINS + 
PHENOLS + 
TANNINS - 
SAPONINS + 
PROTEINS + 
ANTHOCYANIN - 
BETACYANIN - 
QUINONES - 
 
+   Indicates positive 
-  Indicates Negative 
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Quantitative estimation of phytoconstituents of  SAMUTHRA PAZHA NEI 
Determination of total Phenol content 
 The total phenol content was determined using Folin–Ciocalteu reagents with 
analytical grade Gallic acid as the standard. 1 ml of sample was added to deionized 
water (10 ml) and Folin–Ciocalteu phenol reagents (1ml). After 5 minutes, 20% sodium 
carbonate (2 ml) was added to the mixture. After being kept in total darkness for 1 hr, 
the absorbance was measured at 750 nm using a spectrophotometer. Amounts of total 
Phenol was calculated using Gallic acid calibration curve. The results were expressed 
as Gallic acid equivalents (GAE) mg/g of dry plant matter. 
Reference 
Ganesh N. Sharma K, Nitin S, Jyotsana S. Phytochemical screening and estimation of 
Total Phenolic Content in Aegle marmelos Seeds. Int J Pharma Clinc Res.2011; 3(2): 
27-29.  
Total Flavonoid 
Total flavonoid content in the drug SPN was determined using aluminum chloride 
method . In this method Quercetin was used as standard and flavonoid contents were 
measured as quercetin equivalent. For this purpose, the calibration curve of quercetin 
was drawn. 1ml of standard or sample SPN was taken into 10ml volumetric flask, 
containing 4ml of distill water. 0.3ml of 5%NaNO2 added to the flask. After 5min, 
0.3ml 10%AlCl3 was added to the mixture. At the 6th min add 2ml of 1M NaOH was 
added and volume made up to 10ml with distills water. The absorbance was noted at 
510nm using UV-Visible spectrophotometer. 
Reference 
Olajire A. A and Azeez L Total antioxidant activity, phenolic, flavonoid and ascorbic 
acid contents of Nigerian vegetables., 2011; 2(2) 022-029,African Journal of Food 
Science and Technology 
 
 
117 
 
Estimation of Alkaloid 
 SPN weight equivalent to 5 gm was weighed into a 250 ml beaker and 200 ml 
of 10% acetic acid in ethanol was added and covered and allowed to stand for 4 hr. This 
was filtered and the extract was concentrated on a water bath to one-quarter of the 
original volume. Concentrated ammonium hydroxide was added drop wise to the 
extract until the precipitation was complete. The whole solution was allowed to settle 
and the precipitated was collected and washed with dilute ammonium hydroxide and 
then filtered. The residue is the alkaloid, which was dried and weighed. 
Reference 
Ganga rao B, Umamaheswara rao, Sambasiva rao, Mallikarjuna rao T. Studies on phyto 
chemical constituents, quantification of total phenol, alkaloid content and In-vitro anti-
oxidant activity of Coccinia cordifolia. Int. J. pharm. life sci.2011; 2(10):1177-1182. 
Phyto- constituents SPN 
Total phenols             (GAE mg/gm)  0.70 ± 0.125 
Total flavanoids          (Quercetin mg/gm)  0.30 ± 0.01 
Total alkaloids(mg/gm) 0.22 ± 0.03 
Mean with 3 replicates ± SD. 
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   GCMS- Analysis of Samuthra pazha nei 
GCMS (Clarus 500 Perkin – elmer (Auto system XL)), NIST Ver.2.1 MS data library 
Specification : 
Start Time(min)   End Time(min)   Start m/z  End m/z Scan   Speed 
2.50   18.00   50.00       650.00   2000 
Sample Inlet Unit: GC 
 GC-MS Plays a key role in the analysis of unknown components of plant origin. 
GC-MS ionizes compound and measures their mass numbers. Ionization method 
includes EI (Electron Ionization). The EI method produces ions by colliding thermal 
electrons emitted from a filament with sample gas molecules. This method provides 
high stability in ionization and obtained mass spectra show good reproducibility. The 
EI method provides good result for quantitative analysis as well. Quantitative analysis 
with GC-MS, in which only ions specific to the compounds are measured, is highly 
selective method without interfering components. Gas chromatography Technique 
involves the separation of volatile components in a test sample using suitable capillary 
column coated with polar or non-polar or intermediate polar chemicals. Elite-1 column 
(100% Dimethyl polysiloxane) is a non-polar column used for analysis of phyto-
components. Elite -5 column (5% phenyl and 95% methyl polysiloxane) is an 
intermediate column and also used for the estimation of Phytochemical. An inert gas 
such as hydrogen or nitrogen or helium is used as a carrier gas .The compounds of test 
sample is evaporated in the injection port of the GC equipment and segregated in the 
column by absorption and adsorption technique with suitable GC programme. 
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GC-MS CHROMATOGRAM OF SPN 
 
Peak Report of SPN 
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PEAK 9 
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TLC Analysis of Samuthra pazha nei  
Project ID  : NRS/AS/0024/02/2017 
Institute  : National Institute of Siddha 
Sample Name  : Samuthra Pazha Nei 
Sample ID   : SPN  
TLC Analysis 
Test sample SPN was subjected to thin layer chromatography (TLC) as per 
conventional one dimensional ascending method using silica gel 60F254, 7X6 cm 
(Merck) were cut with ordinary household scissors. Plate markings were made with soft 
pencil. Micro pipette were used to spot the sample for TLC applied sample volume 10-
micro liter by using pipette at distance of 1 cm at 5 tracks. In the twin trough chamber 
with different solvent system Ethyl acetate: Methanol: Water (100:13.5:10) After the 
run plates are dried and was observed using visible light Short-wave UV light 254nm 
and light long-wave UV light 365 nm 
Sample Spotting 
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Visible Short UV     Long UV 
 
 
 
 
 
 
Reference 
Lukasz Komsta, Monika Waksmundzka-Hajnos, Joseph Sherma .Thin Layer 
Chromatography in Drug Analysis .CRC Press, Taylor and Francis. 
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High Performance Thin Layer Chromatography Analysis 
HPTLC method is a modern sophisticated and automated separation technique derived 
from TLC. Pre-coated HPTLC graded plates and auto sampler was used to achieve 
precision, sensitive, significant separation both qualitatively and quantitatively. High 
performance thin layer chromatography (HPTLC) is a valuable quality assessment tool 
for the evaluation of botanical materials efficiently and cost effectively. HPTLC 
method offers high degree of selectivity, sensitivity and rapidity combined with single-
step sample preparation. In addition it is a reliable method for the quantitation of nano 
grams level of samples. Thus this method can be conveniently adopted for routine 
quality control analysis. It provides chromatographic fingerprint of phytochemicals 
which is suitable for confirming the identity and purity of medicinal plant raw 
materials.  
Chromatogram Development 
It was carried out in CAMAG Twin Trough chambers. Sample elution was carried out 
according to the adsorption capability of the component to be analysed. After elution, 
plates were taken out of the chamber and dried. 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print was 
developed for the detection of phytoconstituents present in each extract and Rf values 
were tabulated. 
Reference 
1. Wagner H. Plant Drug Analysis. A thin Layer chromatography Atlas.2nd ed. 
Heidelberg: Springer-Verlag Belgium; 2002:305, 227.  
HPTLC Chromatographic condition  
Sample   : SPN 
Derivatization Solvent :Anisaldehyde 
Stationary phase  : Silica gel GF254 
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Mobile phase   : Chloroform : Hexane: methanol (6:3:1)  
Scanning wavelength  : 200-400 nm 
Sample concentration  : 10mg/ml  
Applied volume             : 5 µl  
Application mode          : CAMAG HPTLC 
TLC CHROMATOGRAM OF SPN 
 
HPTLC CHROMATOGRAM OF SPN 
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Peak Table of HPTLC finger printing of SPN 
 
In-vitro Anti-Inflammatory Activity by Protein (Albumin) denaturation Assay 
Project ID  : NRS/AS/0029/02/2017 
Institute  : National Institute of Siddha 
Sample Name  :SamuthraPazhaNei 
Sample ID   : SPN 
Sample Stock prepared using Hexane 
Albumin Denaturation Assay Procedure 
In-vitro anti-inflammatory activity SamuthraPazhaNei(SPN) was studied using albumin 
denaturation technique. The reaction mixture consisted of bovine serum albumin (5% 
aqueous solution) and test sample SPN at varying concentration ranges from 100 to 500 
mcg/ml and standard diclofenac sodium at the concentration of100 mcg/ml of final 
volume. pH was adjusted by using a small amount of 1N Hydrochloric acid. The 
samples were incubated at 37°C for 20 min and then heated at 57°C for 3 min. After 
cooling the sample, 2.5 ml of phosphate buffer solution was added into each test tube. 
Turbidity developed was measured spectrophoto-metrically at 660 nm, for control 
distilled water was used instead of test sample while product control tests lacked bovine 
serum albumin. The experiment was performed in triplicate. 
The Percentage protection from denaturation is calculated by using the formulae 
129 
 
 
Statistical analysis 
Results are expressed as Mean ± SD. The difference between experimental groups was 
compared by One-Way Analysis Of Variance (ANOVA) followed by Dunnet Multiple 
comparison test 
Preparation of Test and control 
 
  Absorbance of reaction mixture – Test Sample 
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Absorbance of reaction mixture – Control and Standard 
 
Absorbance Range of test and standard at Trial 1 
Absorbance Range of test and standard at Trial 2 
 
Absorbance Range of test and standard at Trial 3 
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FINAL RESULT 
Concentration in µg/ml  Absorbance 
Control 0.88  ± 0.02 
SPN 100 0.76  ± 0.026 
SPN 200  0.67  ± 0.011 
SPN 300 0.59  ± 0.015 
SPN 400 0.54  ± 0.046 
SPN 500 0.46  ± 0.057 
Diclofenac sodium(100 µg) 0.01  ± 0.005 
   Each value represents the mean ± SD. N=3 
Concentration in µg/ml Percentage Inhibition of Protein 
Denaturation 
SPN 100 2.30  ± 1.85 
SPN 200 12.1  ± 2.63 
SPN 300 20.78  ± 2.40 
SPN 400 26.88  ± 2.04 
SPN 500 35.58  ± 3.47 
Diclofenac sodium                (100 µg) 86.81  ± 2.76 
  Each value represents the mean ± SD. N=3 
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Result Analysis 
The result obtained from the present clearly indicates that the test drug SPN was 
effective in inhibiting heat induced albumin denaturation. Maximum percentage 
inhibition of about 35.58 % was observed at 500 μg/ml when compare to that of the 
Diclofenac sodium, a standard anti-inflammatory agent with the maximum inhibition 
86.81 % at the concentration of 100 μg/ml. 
Conclusion 
From the result of the study it was concluded that the test drug SPN possess promising 
anti-inflammatory property in protein denaturation assay. 
Reference 
1. G.Leelaprakash, S.MohanDass. In-vitro anti-inflammatory activity of methanol 
extract of enicostemmaaxillare. Int. J. Drug Dev. & Res., 2011, 3 (3): 189-196. 
2. M. V. Anoop, A. R. Bindu . In-vitro Anti-inflammatory Activity Studies on 
Syzygiumzeylanicum (L.) DC Leaves. International Journal of Pharma Research & 
Review, August 2015; 4(8):18-27. 
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Statistical analysis for clinical study 
 All corrected data were entered into MS Excel software using different columns 
as variable and rows as patients. SPSS software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross tabulations were 
performed. The quantity variables were expressed as Mean± standard deviation and 
qualitative data as percentage. A probability value of <0.05 was considered to indicate 
as statistical significance. Paired „T‟ test was performed for determining the 
significance between before and after treatment. 
 The Mean± standard deviation of symptom score at before and after treatment 
were 10.07 and 2.45 respectively which is highly significant. 
Treatment Mean±Std T Value P Value 
Before 10.07 26.68 <0.000% 
After 2.45 
 
 There is significant difference between before and after treatment i.e. 
76%reduction in clinical symptoms after the treatment. 
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Discussion 
 Neer peenisam is mentioned in yugi vaithya chinthamani such as headache, 
lacrimation, nasal block, nasal itching, ear discharge, running nose, cough with 
expectoration, absence of taste may be correalated with maxillary sinusitis. 
 40% cases of neer peenisam were diagnosed based on clinical symptoms and x-
ray paranasal sinus. All the cases were treated in outpatient department of Ayothidoss 
pandithar hospital, National Institute of Siddha, Tambaram, Sanatorium and Chennai 
47. 
 The various siddha &modern methods of examination of the diseases were 
carried out and the data were recorded in proforma. 
 The trial medicine selected for internal treatment is samuthra pazha nei. The 
trial drug smuthra pazha nei will be given continuously for 48 days. For Op patients, 
they should visit the hospital once in 8 days. At each clinical visit clinical assessment is 
done and prognosis is noted, laboratory investigations & radiological investigation will 
be done on the 0
th
 day and 48
th
 day of the trial. After the end of the treatment also, the 
patient is advised to visit the OPD for another 2 months for follow – up. 
 The biochemical, pharmacological studies of the trial drug was done in the 
laboratories and the results were documented. 
Gender distribution: 
 Though neer peenisam affects both male and females. Among 40 cases the 
prevalence of the disease was found to be higher in females (25 cases 62.5%). (Fig -1) 
Age: 
   Among 40 cases the prevalence of disease was found to be higher among the 
age group of 26-33 (13 cases, 32.5%). 27.5% of cases were belongs to 34-41 age group, 
25% of cases were belongs to 18-25and 15% of cases were belongs to 42-50 age group. 
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Occupation:  
 Among 40 patients, (45%) 18 cases were house wives, 5 cases (12.5%) were 
electricians and 4 cases (10%) were students and workers, 5% were IT profession, bank 
staff and jobless, 2.5% were Police, driver and driver.  
Family history: 
 Among 40 cases, 97.5% of patients do not have any family history. Only 
2.5% of patients had family history. 
 
Diet habit: 
 Among the 40 cases, all of them were under Non-Vegetarian category.  
Kaalam: 
 Among 40 cases, 57.5% of patients were in vaatha kaalam (age up to 33 years). 
42.5% of patients were in Pithakaalam (age up to 34-66 years). 
Chronicity of illness: 
 Among 40 cases, 65% patients had 18 months chronicity of illness, 20% of 
patients had 12-18 months chronicity, 12.5% of cases had 2-6 months chronicity and 
2.5% of patients had 6-12 months chronicity. 
Gunam:  
 Among 40 cases, all of them had Raso gunam. 
Past history: 
Among 40 cases, 65% of patients don‟t have any past history. Only 35% of 
cases had past history of Peenisam. 
Triggering factor: 
 Among 40 cases, 60% of patients had cold exposure, 35% of patients had dust, 
5% of cases had smoke as triggering factors. 
Thinai: 
 Among 40 cases, 65% of cases were belongs to Neithal nilam, 30% of cases 
belongs to Marutha nilam, 5% of cases were belongs to Kurinji nilam. 
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Paruvakaalam: 
 Among 40 cases, 60% of patients were suffered in Munpanikaalam, 20% of 
patients were suffered in Pinpani kaalam and another 20% of cases were suffered in 
ilavvenil kaalam 
Changes in Gnanenthiriyam: 
 Among 40 cases, all the patients had Nasal obstruction, temporary anosmia. 
30% of patients had Dullness of both eyes, 12.5% of patients had Ear obstruction.  
Changes in Kosangal: 
 Among 40 cases, all of them were affected with Annamayakosam, Piranamaya 
kosam, and Manomaya kosam in before treatment. After treatment 20% of patients 
were affected with Annamaya kosam and piranamayakosam, and 10% of cases were 
affected with manomayakosam. 
Derangements of Vaatham: 
 Among 40 cases, before treatment all of them were affected with Piranan, 
Udhanan, Smaanan, Kirukaran and Devathathan, 15% of cases were affected with 
Abaanan, 10% of cases were affected with Viyanan, 25% of cases were affected with 
Koorman. 
 After treatment, 40% of cases were affected with Piranan, Samaanan and 
Kirukaran, 20% of cases were affected with Udhanan, and 7.5% of cases were 
affected with Devathathan. 
Derangements of Pitham: 
 Among 40 cases, 70% of patients were affected with Aalosaga pitham in 
before treatment. After treatment, only 20% of patients were affected with 
Aalosagaptham. 
Derangements of Kabam: 
 Among 40 cases, 65% of patients were affected with Avalambagam and 
Tharpagam in before treatment. After treatment it was affected in only 20% of patients. 
Changes in Udal thathukkal: 
 Among 40 cases, 100% of patients were affected with Saaram, 30% of patients 
were affected with Senneer in before treatment. After treatment 20% of patients were 
affected with Saaram. 
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En vagai thervu: 
 Among 40 cases, 70% of patients were affected with Sparisam, 65% of patients 
were affected with Mozhi, 30% were affected with Vizhi, 15% were affected with 
Naaand 5% were affected with Malam in before treatment.  
After treatment 10%  of patients were affected with Sparisam and Vizhi, 20% 
were affected with Moizhi and 2.5% were affected with Naa.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Neerkuri and Neikkuri: 
 50% of  Cases of  Neikuri showed pitha neeer,  20% of  cases of  Neikuri 
showed vatha neer,  30% of  cases of  Neikuri  showed  kabha  neer.  
Clinical features: 
Among  40 cases, 100% of patients  had  Rhinorrhoea  and  sneezing , 97.5%  
had  Head ache  and  facial pain 75%  of  patients  had  Nasal obstruction, 35% of  
patients  had  Post nasal dripping in before treatment. 
 After treatment, 37.5% of patients had Rhinorrhoea and sneezing, 32.5% had 
head ache and facial pain and 10% had Nasal obstruction. 
Chemical analysis:  
 The chemical study of the trial drug reveals Chloride, Carbonate, Iron, 
potassium, Alkaloid. 
Pharmacological Study: 
 The Pharmacological study reveals that the trial drug has Anti-inflammatory 
activity. 
Physico-chemical analysis, Phyto chemical analysis, Gas Chromatography with 
Mass Spectrometry, Thin Layer Chromatography, and High Performance Thin Layer 
Chromatography has also be done for trial drug. 
Results:  
 Among 40 cases, 30% of patients showed Good improvement, 50% showed 
Moderate improvement, 12.5% showed Mild improvement and 7.5% showed Poor 
improvement. 
 Clinical symptoms were reduced well, but X- ray changes not markedly 
improved. Only 25% of cases showed reduced haziness changes in X-ray report. 
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Summary  
 The aim of the study is to evaluate the therapeutic efficacy of Samuthra Pazha Nei 
in Neer Peenisam. 
 The Protocol of this study had been submitted to Institutional Ethics Committee of 
National Institute of siddha. On 26-08-2015 and then approval was got from IEC for 
conducting this clinical study. The IEC no is NIS/iec/9/2014-15/4-26.08.2015. 
 This clinical study was registerd in Clinical Trial Registry of India on 7-3-17. And 
the CTRI NO is CTRI/2017/03/008053 
 The herbal raw drugs were purchased from raw drugs store of Paris corner and 
authenticated by Botanist Dr.D.Aravind,MD(S), M.Sc(Medicinal Plants)., National 
Institute Siddha and Metals were authendicated by Siddha Central Research 
Institute, Arumbakkam and the medicine was prepared in the Gunapadam 
laboratory of National Institute of Siddha. 
 Most of the ingredients of the drug Samuthra Pazha Nei possess anti Inflammatory, 
Analgesic and anti-oxidant activity. 
 Biochemical Analysis (Qualitative Analysis) was done in the Biochemistry lab of 
National Institute of Siddha and Qualitative Analysis& Quantitative analysis was 
done in Sathyabama University. 
 For the clinical study,  70 cases were screened and 40 cases were selected based on 
the Inclusion and Exclusion criteria. All the cases were treated in OPD of 
Ayothidoss Pandithar Hospital of NIS, Chennai. 
 The clinical Trial was conducted in 40 patients of Neer Peenisam with the trial drug 
Samuthra Pazha Nei at the dose of 4ml twice a day with adjuvant of hot water for 
48 days. 
 Blood Investigation was carried out before and after treatment and data were 
recorded in the case report forms. 
 Radiological Invastigations (X-ray for Para nasal sinuses) were also done before 
and after treatment. 
 Clinical assessment Progress was done once in 8 days for OPD patients. 
 The Pharmacological study reveals that the trial drug has Anti-inflammatory 
activity. 
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 Physico-chemical analysis, Phyto chemical analysis, Gas Chromatography 
withMass Spectrometry, Thin Layer Chromatography, HighPerformance Thin 
Layer Chromatography has also be done for trial drug. 
 Biochemical parameters: 
Absolute eosinophil count: 
Out of 40 patients, 17.5% of patients had elevated absolute eosinophil count in 
before treatment. After treatement AEC levels of 12.5% of patients become normal and 
5% of patients were moderately reduced. 
 Erythrocyte sedimentation rate: 
 Out of 40 patients, after treatment ESR of 15% of patients become normal, 20 % 
of patients moderately reduced and 15% of patients were increased. 
 X-ray Para nasal sinuses : 
 X-rays of PNS shows moderate clearance of sinuses in 25%(10 patients)  
 Clinical symptoms: 
 Clinical symptoms showed 30% of patients good improvement, 50% of patients 
moderate improvement, 12.5% of patients mild improvement and 7.5% of patients poor 
improvement. 
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CONCLUSION 
 Clinical study reveals that the trial drug showed good improvement in 30% of 
cases, moderate improvement in 50 cases, mild improvement in 12.5% of cases 
and poor improvement in 7.5% cases.  
 Moderate reduction in blood parameters Absolute eosinophil count and ESR 
levels. 
 30 % of patients showed moderate clearance of paranasal sinuses in x-rays, 
 During the course of the treatment adverse drug reactions were not found. 
 The pharmacological study revealed the trial drug had Anti inflammatory 
activity. 
 Physico chemical, phyto chemical, GCMS,TLC and HPTLC analysis showed 
phytoconstituents which is responsible for therapeutic action. 
 Because of the encouraging clinical and laboratory results, the study may be 
extended with the same drug in more number of cases, in treating Neer 
peenisam successfully. 
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Title of Study  
Clarification(s) 
with Reply  
Modification(s) 
  
Clinical Evaluation Of Siddha drug Samuthra pazha 
nei in the treatment Of Neer peenisam (Maxillary 
Sinusitis)   
Acronym    
Secondary 
IDs if Any   
Secondary ID  Identifier  
NIL  NIL  
  
Details of 
Principal 
Investigator 
or overall 
Trial 
Name  Dr U MULLAIKARASI  
Designation  Pg Scholar  
Affliation  NATIONAL INSTITUTE OF SIDDHA  
146 
 
Coordinator 
(multi-center 
study)  
Clarification(s) 
with Reply  
Modification(s) 
  Address  
Department Of Maruthuvam National 
Institute Of Siddha Ayothdhasar 
Pandithar Hospital Tambaram 
Sanatorium Chennai  
Department Of Maruthuvam National 
Institute Of Siddha Ayothidhasar 
Pandithar Hospital Tambaram 
Sanatorium Chennai 
Kancheepuram 
TAMIL NADU 
600047 
India  
Phone  9750871667   
Fax     
Email  drmullaiamo@gmail.com   
  
Details 
Contact 
Person 
Scientific 
Query  
Clarification(s) 
with Reply  
Modification(s) 
  
Name  DR PERIYASAMY PANDIAN  
Designation  Associate professar  
Affliation  
National institute of siddha 
Ayothidhasar Pandithar Hospital  
Address  
Department Of Maruthuvam National 
Of Institute Of Siddha Ayothidhasar 
Pandithar Hospital Tambaram 
Sanatorium Chennai 
Department Of Maruthuvam National 
OF Institute Of Siddha Ayothidhasar 
Pandithar Hospital Tambaram 
Sanatorium Chennai 
Kancheepuram 
TAMIL NADU 
600047 
India  
Phone  9500151930   
Fax  9500151930   
Email  periasamypandian22@gmail.com   
  
Details 
Contact 
Person 
Public Query  
Clarification(s) 
with Reply  
Name  DR H VETHA MERLIN KUMARI  
Designation  Lecturer  
Affliation  National Institute Of Siddha   
Address  
Department Of Maruthuvam National 
Institute Of Siddha Ayothidhasar 
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Modification(s) 
  
Pandithar Hospital Tambaram 
Sanatorium Chennai 
Department Of Maruthuvam National 
Institute Of Siddha Ayothidhasar 
Pandithar Hospital Tambaram 
Sanatorium Chennai 
KANCHEEPURAM 
Kancheepuram 
TAMIL NADU 
600047 
India  
Phone  9894782366   
Fax  044-22381314   
Email  dr.vetha@gmail.com   
  
Source of 
Monetary or 
Material 
Support  
Clarification(s) 
with Reply  
Modification(s) 
  
National Institute Of Siddha Ayothidhasar Pandithar 
47 Hospital Tambaram Sanatorium Chennai  
  
Primary 
Sponsor  
Clarification(s) 
with Reply  
Modification(s) 
  
Name  Ayothidhasar Pandithar Hospital  
Address  
National Institute Of Siddha 
Department Of Maruthuvam 
Tambaram Sanatorium Chennai 47  
Type of 
Sponsor  
Research institution and hospital  
  
Details of 
Secondary 
Sponsor   
Name  Address  
NIL  NIL  
  
Countries of 
Recruitment   
  India   
Sites of 
Study  
Clarification(s) 
with Reply  
Modification(s) 
  
No of Sites = 1   
Name of 
Principal 
Investigat
or  
Name 
of 
Site  
Site 
Address  
Phone/Fax/Emai
l  
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Dr U 
MULLAIKAR
ASI  
Nation
al 
Institu
te of 
Siddh
a  
OPD NO 1 
Departmen
t of 
Maruthuva
m National 
Institute of 
siddha 
Tambaram 
Sanatoriu
m chennai 
47 
Kancheepu
ram 
TAMIL 
NADU  
9750871667 
 
drmullaiamo@gmai
l.com  
  
Details of 
Ethics 
Committee  
Modification(s) 
  
No of Ethics Committees= 1   
Name of 
Committee  
Approv
al 
Status  
Date of 
Approval  
Approval 
Documen
t  
Is 
IEC?
  
INSTITUTIN
AL ETHICAL 
COMMITTEE  
Approve
d  
26/08/201
5  
Approval 
File  
No  
  
Regulatory 
Clearance 
Status from 
DCGI   
Status  Date  
Aproval 
Document  
Not 
Applicable  
No Date 
Specified  
No File Uploaded  
  
Health 
Condition / 
Problems 
Studied  
Health 
Type  
Condition  
Patients  
NEER PEENISAM (Maxillary 
sinusitis)  
  
Intervention 
/ Comparator 
Agent  
Type  Name  Details  
Comparator 
Agent  
NIL  NIL  
Intervention  
SAMUTHRAPAZHA 
NEI (INTERNAL)  
4 ml of 
samuthrapazha 
nei administered 
orally twice a day 
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for a period of 48 
days  
  
Inclusion 
Criteria  
Clarification(s) 
with Reply  
Modification(s) 
  
Age 
From  
18.00 Year(s) 
Age To  50.00 Year(s) 
Gender  Both  
Details  
1)18-50 years 
 
2)Both male & female 
 
3)The symptoms of pain in the face 
purulent 
 
nasal discharge and headache/heaviness 
of 
 
head sneezing fever tooth ache nasal 
block 
 
and presence of any three symptoms will 
be 
 
taken as inclusion criteria. 
 
4)Patient willing to sign the informed 
consent 
stating that he/she will conscientiously 
stick to the treatment during 48 days but 
can opt out of the trial of his/her own 
conscious discretion. 
5)Patients who are willing for radiological 
investigation (X-ray for Paranasal 
sinuses) and 
provide blood urine for lab investigation.  
  
Exclusion 
Criteria  
Details  
1) Bronchial asthma 
 
2)Tuberculosis 
 
3)Diabetes mellitus 
 
4)Hypertension 
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5)Pregnancy and lactation 
 
6)Heart disease  
 
7)Chronic obstructive pulmonary disease  
  
Method of 
Generating 
Random 
Sequence  
Not Applicable  
Method of 
Concealment 
  
Case Record Numbers  
Blinding/Mas
king  
Open Label  
Primary 
Outcome  
Clarification(s) 
with Reply  
Modification(s) 
  
Outcome  TimePoints  
Outcome is mainly assessed by 
laboratory and clinical symptom 
scoring.  
48 days  
  
Secondary 
Outcome  
Clarification(s) 
with Reply  
Modification(s) 
  
Outcome  TimePoints  
Secondary outcome will be assesed 
by comparing the following 
parameters pre and post treatment. 
Influence of other co factors related 
to the disease such as age sex etc. 
Changes in other investigation like 
DC ESR AEC etc   
48 days  
  
Target 
Sample Size   
Total Sample Size="40" 
Sample Size from India="40"  
Phase of 
Trial   
Phase 3  
Date of First 
Enrollment 
(India)  
Clarification(s) 
with Reply  
Modification(s) 
  
15/03/2017  
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Date of First 
Enrollment 
(Global)  
No Date Specified  
Estimated 
Duration of 
Trial   
Years="0" 
Months="6" 
Days="0"  
Recruitment 
Status of Trial 
(Global)  
Clarification(s) 
with Reply  
Modification(s) 
  
Not Applicable  
Recruitment 
Status of Trial 
(India)  
Not Yet Recruiting  
Publication 
Details   
NONE YET  
Brief 
Summary  
Clarification(s) 
with Reply  
Modification(s) 
  
 It is a single non- randomized, open- label trial to 
determine the efficacy of SAMUTHRAPAZHA NEI 
(prepared from herbal and mineral constituents such 
as Barringtonia acuteangula(dry fruit), Zingiber 
officinale, Allium sativum, Root of moringa oleifera, 
Root of Plumbago zeylanica, Carum 
copticum,Sodium chloride (rock salt), Zingiber 
officinale(dry ginger),Piper nigrum, Piper longum, 
Root of piper longum(seviyam), Ammonium 
chloride(navacharam), Nigella sativum,Cuminum 
cyminum, Cissus quadrangularis and ghee) in 
patients with Neer peenisam(MAXILLARY 
SINUSITIS). In this trial 40 patients  will be 
recruited and the  trial drug will be administered 4 
ml twice a day for a period of 48 days.During the 
trial period if any AE/SAE/SUSAR will be noticed and 
referred to pharmacovigilance dept in NIS and 
further management will also be given in NIS 
OPD/IPD. The entire trial will be monitored by the 
research monitoring committee of NIS. During this 
trial all the safety efficacy parameters will be 
recorded in the CRF .After completion of the trial all 
the study related data will be analysed statistically. 
The outcome of this trial will be published in Indian 
journal of Medical Research.     
  
 
152 
 
 
 
 
153 
 
 
 
 
 
 
 
 
154 
 
 
 
155 
 
 
 
 
156 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
CLINICAL EVALUATION OF “SAMUTHRAPAZHA NEI” IN THE 
TREATMENT OF NEER PEENISAM” (MAXILLARY SINUSITIS). 
FORM I SCREENING & SELECTION PROFORMA 
REG NO:  
1. STUDY  NO______                                               2. OP /IP NO:_________ 
3. NAME :____________________________          4. AGE/SEX_______ 
5. RELIGION: H / C / M / O                                    6. OCCUPATION & INCOME: 
_    
7. CONTACT NO: 
INCLUSION CRITERIA: 
 Facial pain, purulent nasal discharge, nasal block, headache/ heaviness of head, 
sneezing, fever, tooth pain. 
 Age 18 to 50yrs       Yes/No 
 Sex       Male/Female 
 Patient willing to under go lab investigations   Yes/No 
 Patient willingness for consent to include in the trial               Yes/No                     
 Patient willingness for radiological investigation(x ray of paranasal sinuses).  
         Yes/No 
 EXCLUSION CRITERIA: 
        Bronchial asthma                                                                  Yes/No              
        Tuberculosis                                                                             Yes/No  
        Diabetes mellitus                                                                    Yes/No 
        Hypertension                                                                           Yes/No 
        Heart disease                                                                           Yes/No 
        Chronic obstructive pulmonary disease                                     Yes/No 
        Pregnancy & lactation                                                             Yes/No 
 
ADMITTED TO TRAIL:    YES         NO                     If Yes Serial NO:  
 
Date: 
Station: 
 
Signature of the Investigator:                                                        
 
Signature of the Lecturer:     Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
CLINICAL  EVALUATION  OF  “SAMUTHRAPAZHA NEI” IN THE 
TREATMENT OF NEER PEENISAM” (MAXILLARY SINUSITIS). 
FORM II-CASE RECORD  FORM 
IEC NO:  
 
1. Serial No of the patient:   _______________                 
OP.NO/IP.NO:________________ 
 
2. Name: _____________________________________      3. Gender: F/M 
 
4. Age (years): _________    DOB    
      
5. Address: 
_______________________________________________________________ 
 
6. Occupation: ____________________ 
 
7. Educational Status:   A) Illiterate                     B) Literate  
 
8. Height:         ____cm                9.Weight:         _____kg        10. BMI: ________ 
kg/m² 
 
11. Marital status:    1.Married   2.Unmarried 
 
10. Complaints and Duration:   
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________
______________________________________________________________________ 
11. History of present illness: 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
 
12. Past History: 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
 
13. Socio economic status: 
 
Income group  1.lower   2.middle   3.higher 
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14. Treatment History: 
 
Had the patient been treated before with Allopathy drug? Yes  No 
 
15. Family history: 
 
Whether Allergic rhinitis, Bronchial asthma, Allergic dermatitis runs in family? 
 
1) Yes           2) No 
 
If yes, mention the relationship of affected person(s) 
1. ______________ 
2. ______________ 
3. ______________ 
 
16. Habit of 
 
A) Smoking                   1. Yes; duration ________ years;                       2.No 
 
B) Tobacco chewing       1. Yes; duration ________ years                  2.No                  
 
C) Betel chewing            1. Yes; duration ________ years       2.No 
 
D) Alcoholism               1. Yes; duration ________ years;                      2.No 
 
17. Dietry style:  A) Pure vegetarian         B) Non-vegetarian     C) mixed diet 
 
SIDDHA SYSTEM OF EXAMINATION: 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
I. NAADI: [PULSE PERCEPTION] 
NAADI BEFORE 
TMT 
AFTER 
TMT
 
NAADI BEFORE 
TMT 
AFTER 
TMT
 
Vali   Iyya vali   
Azhal   Vali Iyyam   
Iyyam   Azhal Iyyam   
Vali Azhal   Iyya Azhal   
Azhal vali      
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II. NAA:[TONGUE] 
 BEFORE TMT AFTER TMT
 
Colour Dark/Yellow/Red / Pale/Normal Dark/Yellow/Red/Pale/Normal 
Taste Sweet/Bitter/Sour 
Pungent/None 
Sweet/Bitter/Sour 
Pungent/None 
Coating Present/Absent Present/Absent 
Fissure Present/Absent Present/Absent 
Saliva Normal/Increased/Decreased Normal/IncreasedDecreased 
Dryness Present/Absent Present/Absent 
Glossitis Present/Absent Present/Absent 
Baldness Present/Absent Present/Absent 
 
III.NIRAM: [COMPLEXION]    
           BEFORE TMT                        AFTER TMT
 
 
Dark/Yellow tinted/   Wheatish brown / 
Pale 
 
Dark/Yellow tinted  / Wheatish brown/ Pale 
IV.MOZHI: [VOICE] 
                        BEFORE TMT               AFTER TMT
 
Medium/High/Low pitched Medium/High/Low pitched 
 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva) 
BEFORE TMT AFTER TMT
 
Yellow 
Red/ Pale/Normal 
Yellow 
Red/ Pale/Normal 
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VI. MALAM; [BOWEL HABITS / STOOLS] 
Malam BEFORE TMT AFTER TMT
 
 
Colour 
 
Dark/ Yellow/Pale/Others 
 
Dark/ Yellow/Pale/Others 
 
Consistency 
 
Solid/Semisolid/Watery 
 
Solid/Semisolid/Watery 
 
Stool  bulk                          
 
Normal/Reduced 
 
 
Normal/Reduced 
 
Constipation   
 
Present/Absent 
 
 
Present/Absent 
 
 
Diarrhoea 
 
Present/Absent 
 
Present/Absent 
 
VII. URINE EXAMINATION: 
 
NEERKURI BEFORE TMT AFTER TMT
 
Niram 
[Colour] 
 
 White/Yellowish/Straw coloured/ 
Crystal clear 
White/Yellowish/ 
Straw coloured/ Crystal clear 
Manam 
[Odour] 
Present/ Absent Present/ Absent 
Nurai 
[Froth] 
Nil/ Reduced/ Increased Nil/ Reduced/ Increased 
Edai 
[Sp.gra] 
Normal/ Increased/ Reduced Normal/ Increased/ Reduced 
Enjal 
[Deposits] 
Present/ Absent Present/ Absent 
Volume Normal/ Increased/ Reduced Normal/ Increased/ Reduced 
NEIKURI     BEFORE TMT             AFTER TMT
 
Serpentine fashion   
Annular/Ringed fashion   
Pearl beaded fashion      
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VIII. SPARISAM: [PALPATORY PERCEPTION]  
BEFORE TMT AFTER TMT
 
 
Warm/Cold/Normal/ Sweat 
 
Warm/ Cold/Normal/Sweat 
 
5. THEGI: [TYPE OF BODY CONSTITUTION]   
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
6. NILAM: [LAND WHERE PATIENT LIVED MOST ] 
  Kurinji                  Mullai                 Marutham              Neithal                  Palai 
7. KAALAM 
Kaarkalam                                               Pinpanikalam      
Koothirkalam                                           Ilavenil 
Munpanikalam                                         Muthuvenil 
8. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
9. AIYMPORIGAL (SENSORY ORGANS) 
Mixed fashion   
Other fashion   
IYMPORIGAL BEFORE TMT AFTER TMT
 
Mei (Skin)   
Vai (Buccal Cavity)   
Kann (Eye)   
Mooku (Nose)   
Sevi  (Ear)   
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10. KANMENDRIYAM (MOTOR ORGANS) 
 
11. KOSANGAL (Sheath)   
KOSANGAL BEFORE TMT AFTER TMT
 
Annamaya Kosam   
Pranamaya kosam    
Manomaya kosam    
Vignanamaya kosam    
Ananthamaya kosam    
 
12. MUKKUTRAM: [AFFECTION OF THREE HUMORS] 
A) VATHAM: 
VATHAM BEFORE TMT AFTER TMT
 
Praanan   
Abaanan   
Samaanan   
Udhaanan   
Viyaanan   
Naagan   
KNMENDRYAM BEFORE TMT AFTER TMT
 
Kai (upper limb)   
Kaal (lower limbs)   
Vai  (buccal cavity)   
Eruvai (excretory organs)   
Karuvai (reproductive organs)   
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Koorman   
Kirukaran   
Devathathan   
Dhananjeyan   
 
B) PITHAM: 
PITHAM BEFORE TMT AFTER TMT
 
Anarpitham   
 Prasakam   
Ranjakam   
Aalosakam   
Saathakam   
 
C) KABAM: 
KABAM BEFORE TMT AFTER TMT
 
Avalambagam   
Kilethagam   
Pothagam   
Tharpagam    
Santhigam   
 13. SEVEN DHATHUS: (7 SOMATIC COMPONENTS) 
 BEFORE TMT AFTER TMT
 
Saaram [Chyme]   
Senneer [Blood]    
Oon [Muscle]   
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Kozhuppu [Fat]   
Enbu [Bones]   
Moolai [Bonemarrow]   
Sukkilam/Suronitham    
 
14. GENERAL EXAMINATION: 
GENERAL EXAMINATION BEFORE TMT AFTER TMT
 
Height (cm)   
Weight (kg)   
Temperature(°F)      
Pulse rate (per min)   
Heart rate (per min)   
Respiratory rate (per min)   
Blood pressure(mm/Hg)   
Pallor   
Jaundice   
Cyanosis   
Lymphadenopathy   
Pedal Oedema   
Clubbing   
Jugular venous pulsation   
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15. SYSTEMIC EXAMINATION: 
 
SYSTEMIC EXAMINATION BEFORE TMT AFTER TMT
 
LOCOMOTOR SYSTEM   
CARDIO VASCULAR  SYSTEM   
RESPIRATORY SYSTEM        
GASTRO INTESTINAL SYSTEM      
CENTRAL NERVOUS  SYSTEM          
UROGENITAL SYSTEM   
ENDOCRINE  SYSTEM   
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16. CLINICAL SYMPTOMS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 = Nil 
1 = mild 
2 = moderate 
3 = severe 
 
DATE: 
STATION: 
 
SIGNATURE OF THE INVESTIGATOR                                
 
 
SIGNATURE OF THE LECTURER                            SIGNATURE OF THE HOD 
1 Rhinorrhoea 
 
2 Nasal obstruction 
 
3 Sneezing 
 
4 
Headache/ Facial 
pain 
 
5 Post nasal dripping 
 
0 1 
2 3 
0 1 
2 3 
0 1 
2 3 
0 1 
2 3 
0 1 
2 3 
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NATIONAL INSTITUTE OF SIDDHA,CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
CLINICAL  EVALUATION  OF  “SAMUTHRAPAZHA NEI” IN THE 
TREATMENT OF NEER PEENISAM” (MAXILLARY SINUSITIS). 
FORM III LABORATORY PARAMETERS-CHART 
1. OP/IP No: ____________       2.S.No:_____         3.Reg no:  
4.Name: ____________________________  5.Age/Sex:______________ 
 
 
BLOOD INVESTIGATION 
NORMAL 
VALUES 
BEFORE 
TMT 
 
AFTER  
TMT 
HB( gms%) 
M:13-18 
W:11-16 
  
 
T.RBC(million cells /cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
 
ESR (mm) 
½ hr. M:0-10 
W:0-20 
  
1 hr.   
T.WBC (cells /cu.mm)       4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Esonophils 1-6   
Basophils 0-1   
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Date : 
Station: 
 
Signature of the Investigator: 
Signature of the Lecturer:   Signature of the HOD 
 
 
 
Blood Investigation Normal Values BeforeTMTDate: AfterTMTDate 
Blood 
glucose 
(mg/dl) 
Fasting 70-110mg/dl   
PP 80-140mg/dl   
Specific  investigation Before TMTDate: After TMTDate: 
X ray of Para nasal sinus   
Absolute esinophil   [40-440                  
cells/cu.mm)] 
  
URINE 
INVESTIGATION 
Before TMT(with Date) After TMT (With Date) 
Albumin   
Fasting sugar   
PP sugar   
Deposite   
Bile salts   
Bile pigments   
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF   MARUTHUVAM 
CLINICAL EVALUATION OF “SAMUTHRAPAZHA NEI” IN THE 
TREATMENT OF NEER PEENISAM” (MAXILLARY SINUSITIS). 
FORM IV – (DRUG COMPLIANCE FORM) 
 
Name:________________ OP/IP No: Serial No: DRUG NAME: _________    
DOSE:___________ (After food) 
 
On 0
th   
day   -Date:  Drugs issued:  Drugs returned:  
  
On 8
th
 day   -Date:    Drugs issued:  Drugs returned:  
 
On 16
th
 day -Date:       Drugs issued:  Drugs returned: 
 
On 24
th
day -Date:  Drugs issued:  Drugs returned: 
 
On 32
th
 day -Date:  Drugs issued:  Drugs returned: 
On 40
th   
day   -Date:  Drugs issued:             Drugs returned:   
On 48
th
 day   -Date:          Drugs issued:  Drugs returned:  
      
Day  Date Morning (7-8 am) Evening (7-8 pm) 
Day 1    
Day2    
Day3    
Day4    
Day5    
Day6    
Day7    
Day8    
Day9    
Day10    
Day11    
Day12    
Day13    
Day14    
Day15    
Day16    
Day17    
Day18    
170 
 
Day19    
Day20    
Day 21    
Day22    
Day23    
Day24    
Day 25    
Day 26    
Day27    
Day 28    
Day29     
Day30    
Day31    
Day32    
Day33    
Day34    
Day35    
Day36    
Day37    
Day38    
Day39    
Day40    
Day41    
Day42    
Day43    
Day44    
Day45    
Day46    
Day47    
Day48    
DATE: 
STATION: 
 
 
SIGNATURE OF THE INVESTIGATOR                                
 
 
 
 
SIGNATURE OF THE LECTURER          SIGNATURE OF THE HOD 
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தேசி஬ சித்ே ஫ருத்துவ நிறுவனம், சசன்னன- 47 
அத஬ோத்ேிேோசர் பண்டிேர் ஫ருத்துவ஫னன 
¿£÷ À£É¢ºõதநோய்க்கோன சித்ே ÁÕó¾¢ý ("ºÓò¾¢ÃÀÆ 
¦¿ö")பரிகரிப்புத் ேிமனனக் கண்டமியும் ஫ருத்துவ ஆய்விற்கோன 
ஒப்புேல் படிவம் 
FORM VI ஒப்புேல் படிவம் 
நோன் த஫ற்கூமி஬ ேகவல் படிவத்னே படித்து அல்யது படிக்க தகட்டுக் 
சகோண்தடன்.அது சேோடர்போன விரக்கங்கனரயும் தகட்டு 
சேரிந்துசகோண்தடன்.எந்ே விே வற்புறுத்ேயின்மி என் சசோந்ே 
விருப்பத்ேின் தபரில் என்னன இந்ே ஆ஭ோய்ச்சிக்கு உட்படுத்ே என் 
முழு஫னதேோடும் சு஬நினனதவோடும் சம்஫ேம் சேரிவிக்கின்தமன். எனக்கு 
விருப்பம் இல்யோே பட்சத்ேில் இந்ே ஆ஭ோய்ச்சி஬ில் இருந்து என்னன 
எப்தபோது தவண்டு஫ோனோலும் விடுவித்து சகோள்ளும் உரின஫ன஬ 
சபற்றுள்தரன் என்பனேயும் அமிதவன் 
தேேி  :      
இடம்  : 
னகச஬ோப்பம்      சோட்சிக்கோ஭ர் 
னகச஬ோப்பம் 
சப஬ர்       சப஬ர் 
உமவுமுனம: 
ÁÕòÐÅ÷ ¨¸¦Â¡ôÀõ: 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASAR PANDITHAR HOSPITAL 
DEPARTMENT OF MARUTHUVAM 
CLINICAL EVALUATION OF “SAMUTHRAPAZHA NEI” IN THE 
TREATMENT OF NEER PEENISAM” (MAXILLARY SINUSITIS). 
FORM VICERTIFICATE OF CONSENT 
“I have read the foregoing information, or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have 
asked have been answered to my satisfaction.  
            I   consent voluntarily to participate as a participant in this study 
and understand that I have the   right to withdraw from the study at any 
time without in any way it affecting my further medical care” 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant 
In case of illiterate participant,\ 
             “I have witnessed the accurate reading of the consent form to the 
potential participant, and the individual has had the opportunity to ask 
questions. I confirm that the individual has given consent freely.”                                                   
Date: 
 Signature of a witness  
      Left thumb Impression of the Participant  
  
 (Selected by the participant bearing no connection with the survey team) 
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FORM VII- WITHDRAWAL FORM/ADVERSE DRUG 
REACTION/PHARMACOVIGILANCE FORM 
 
Reg No: 
Serial No:     OP/IP No: 
Name:       Age:                                          Gender:  M/F 
DATE OF TRIAL COMMENCEMENT:  
DATE OF WITHDRAWAL FROM TRIAL:  
REASONS FOR WITHDRAWAL: 
 Long absence at reporting :                
 Yes/No 
 Irregular treatment:    Yes/No 
 Shift of locality :       Yes/No 
 Increase in severity of symptoms:   
 Yes/No 
 Development of severe adverse drug reactions: 
 Yes/No 
NATIONAL PHARMACOVIGILANCE PROGRAMME 
FOR SIDDHA DRUGS 
 
 
Date of trial commencement: 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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Please note:  i. All consumers / patients and reporters information will remain 
confidential. 
ii. It is requested to report all suspected reactions to the concerned, even if  
it does not have complete data, as soon as possible. 
PeripheralCenter code:     State:  
 
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / 
Female  
Weight : 
Degam: 
2. Description of the suspected Adverse Reactions (please complete boxes 
below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction  
 
 Geographical area: 
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3. List of all medicines / Formulations including drugs of other systems used by 
the patient during the reporting period: 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle - 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  Starting Stopped 
Siddha 
 
 
 
 
     
Any other system 
of medicines 
 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug – 3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the 
drug used 
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b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or 
used as self medication.  
d) Any other relevant information. 
 
5. Treatment provided for adverse reaction: 
 
6. The result ofthe adverse reaction / side effect / untoward effects (please 
complete the boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital?If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities? If Yes 
specify:  
 
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic Renal Cardiac Diabetes Malnutrition  
 
Any Others 
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9. H/O previous allergies / Drug reactions: 
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist/ Health worker / Patient / Attendant / 
Manufacturer/  
Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E – mail if any : 
 
 
Signature of the reporter:       Date: 
Please send the completed form to:  
    The Director 
            National Institute of Siddha, 
(Pharmacovigilance Regional Centre For Siddha Medicine), 
                                                           Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314  Fax : 044 – 22381314 
Website : www.nischennai.org 
        Email: nischennaisiddha@yahoo.co.in 
 
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
Name & address of the RRC-
ASU/ PPC-ASU 
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This filled-in ADR report may be sent within one month of 
observation /occurrence of ADR   
 
 
 
Date:                                                                              
 
Date:                                                                              
Station:  
 
Signature of the Investigator: 
Signature of the Lecturer:                                              Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
Who Can Report?     
 Any Health care professionals like Siddha Doctors /  Nurses / Siddha 
Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 The patient’s identity will be held in strict confidence and protected to the 
fullest extent.  
 Submission of report will be taken up for remedial measures only not for legal 
claim  
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FORM VIII DIETARY ADVICE FORM 
§º÷ì¸ §ÅñÊÂ உணவு¸û §º÷ì¸ கூ¼¡¾¨Å¸û 
 
¸¡ö¸றி¸û: ÓÕí¨¸,¸Õ¨½, 
¸òதிரிபிïÍ, ¾ì¸¡ளி§¸Ãð, þïசி, 
பூñÎ,Àî¨ºì¸¡ö¸றி¸û. 
Àழí¸û: ஆÃïÍ, «ýÉ¡சி,஋லுப௅î¨º, 
¬ôÀ¢û, ÀôÀ¡ளி, ¦¸¡öÂ¡, §ÀÃ£î¨º, 
¸üபூÃÅûளி, ¦ºùÅ¡¨Æ, Á¡õÀÆõ    
கீ¨Ã¸û: ¸ரிº¡¨Ä, 
ப௄ணிò¾ì¸¡ளி,ÓÕí¨¸, 
ÀÕப௃புÅ¨¸¸û 
ÅÃப௃பு¿ñÎ, §Å¸¨Åò¾ Á£ý, Á¢ÇÌ 
§º÷ò¾ Óð¨¼. 
ÝôÅ¨¸¸û: ¿ñÎ, ¬ðÎì¸¡ø, 
¸¡ö¸றி, ¦¸¡¾¢ì¸¨Åò¾¡றிÂ ¦Åó¿£÷   
þïº¢, ÍìÌ §º÷ó¾ ¸¡À¢, Áïºû, 
Á¢ÇÌ §º÷ó¾ À¡ø, ¬Å¢Â¢ø 
§Å¸¨Åò¾ Àñ¼í¸û  ( þðÄ¢, 
þÊÂ¡ôÀõ, ÒðÎ, ¬ôÀõ) 
ÒØí¸ÄÃ¢º¢ º¡¾õ, À¡º¢ôÀÕôÒ 
º¡õÀ¡÷, Á¢ÇÌ Ãºõ,àÐ§Å¨Ç 
Ð¨ÅÂø, ÓÍÓÍì¨¸ «¨¼ 
§ÅÐ: (¬Å¢À¢Êò¾ø) ÐÇசி, ப௄ïºû, 
ÍìÌ ,஋லுப௅î¨º þ¨Ä 
 
 
 
 Ìளி÷À¡Éí¸û(º¡ì§Äð, §¸ì) 
 பு¨¸, àÍ Ìளி÷ó¾ ¸¡üறு, ÀÉ¢  
 §¸¡Æ¢ì¸றி, À¾ôÀÎò¾ôÀð¼ 
¯ண×¸û 
 ¸¡Ç¡ý, ¾யி÷, ஊÚ¸¡ö           
 Áì¸¡î§º¡Çõ  
  
 þனிப௃பு, ÒளிôÒ Àñ¼í¸û 
 ¸¢ÆíÌ Å¨¸¸û, «¸ò¾¢¸£¨Ã 
¦ÅûÇÃ¢, À¡¸ø. 
 Í¨Ãì¸¡ö, பூºணிì¸¡ö, பீ÷ìÌ, 
பு¼¨Ä  
 ¦Åüறி¨Ä, À¡ìÌ, பு¨¸யி¨Ä 
 ப௄Ð«ÕóÐ¾ø 
 À¨ழÂ ¾¨ÄÂ¨É 
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